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https://doi.org/10.1016/j.str.2020.04.010SUMMARYCentrioles are cylindrical assemblies whose peripheral microtubule array displays a 9-fold rotational symme-
try that is established by the scaffolding protein SAS6. Centriole symmetry can be broken by centriole-asso-
ciated structures, such as the striated fibers in Chlamydomonas that are important for ciliary function. The
conserved protein CCDC61/VFL3 is involved in this process, but its exact role is unclear. Here, we show
that CCDC61 is a paralog of SAS6. Crystal structures of CCDC61 demonstrate that it contains two homodi-
merization interfaces that are similar to those found in SAS6, but result in the formation of linear filaments
rather than rings. Furthermore, we show that CCDC61 binds microtubules and that residues involved in
CCDC61 microtubule binding are important for ciliary function in Chlamydomonas. Together, our findings
suggest that CCDC61 and SAS6 functionally diverged from a common ancestor while retaining the ability
to scaffold the assembly of basal body-associated structures or centrioles, respectively.INTRODUCTION
Centrosomes are among the largest protein assemblies found in
animal cells. They function primarily in the organization of the
microtubule cytoskeleton and frequently constitute the dominant
cellular microtubule organizing center. Due to this function, cen-
trosomes play an important role in ensuring faithful cell division
(Nigg and Raff, 2009). Centrosomes are also involved in other
critical cellular processes, such as the formation of functional
immunological synapses (Stinchcombe and Griffiths, 2014), the
organization of actin (Farina et al., 2016), and intracellular
signaling (Arquint et al., 2014).
Centrosomes consist of a pair of barrel-shaped centrioles that
are surroundedbyandorganize thepericentriolarmaterial (PCM),674 Structure 28, 674–689, June 2, 2020 ª 2020 MRC Laboratory of
This is an open access article under the CC BY license (http://creativea proteinaceous matrix that anchors microtubule nucleating
g-tubulin complexes (Woodruff et al., 2014). Small electron-
dense particles called centriolar satellites, which play a role in
centrosomal protein delivery and cellular stress responses (Hori
and Toda, 2016), are frequently found in the vicinity of centrioles.
Besides their function in the recruitment and organization of the
PCM, centrioles are also essential for ciliogenesis. During this
process, the older (mother) centriole docks to the cell membrane
and extends its peripheralmicrotubule array,which gives rise to a
hair-like cell projection that is referred to as a cilium. In multicili-
ated cells, cilia formation is initiated from multiple centrioles
that have been amplified around electron-dense cellular struc-
tures called deuterosomes (Spassky and Meunier, 2017). Cilia
have key roles in cellular functions, such as mechanosensing,Molecular Biology. Published by Elsevier Ltd.
commons.org/licenses/by/4.0/).
ll
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(Fliegauf et al., 2007).
Proteomics analyses identified over 100 different proteins asso-
ciated with human centrosomes (Andersen et al., 2003). Due to a
lack of structural information, the exact roles ofmost of these pro-
teins for the organization and function of the centrosome, as well
as their precise mechanism of action, are currently poorly under-
stood. The highly conserved coiled-coil domain-containing pro-
tein 61 (CCDC61, also known as variable flagellar number 3,
VFL3) is one of these understudied proteins. Unlike wild-type
strains, the vfl3 strain of Chlamydomonas reinhardtii does not
assemble two cilia per cell, but displays between none and six cilia
per cell and consequently shows an altered motility (described as
the Vfl phenotype hereafter) (Wan and Goldstein, 2016; Wright
et al., 1983). The vfl3 mutant has defects in the structure of the
basal body complex; it is missing the associated striated fibers
and contains altered rootlet microtubules (Wright et al., 1983).
Basal body/centriole duplication is also compromised (Marshall
et al., 2001). Recent studies on CCDC61 in the unicellular ciliate
Paramecium tetraurelia showed that the protein plays a crucial
role in the orientation of basal bodies and localizes at the interface
between basal bodies and ciliary rootlets (Bengueddach et al.,
2017). Consistent with these observations, CCDC61 was also
shown to be important for the basal body orientation, and the gen-
eration of basal feet and ciliary rootlets in the multiciliated ventral
epidermis of the flatworm Schmidtea mediterranea (Azimzadeh
et al., 2012; Basquin et al., 2019), where its absence results in
movement defects. Finally, inXenopus laevis, the gene expression
of CCDC61 was found to be upregulated by the expression of
Multicilin, which promotes centriole biogenesis in multiciliated
cells (Stubbs et al., 2012). These studies point toward a potential
role of CCDC61 in the organization of basal bodies in cells with
multiple cilia. A recent report suggests that CCDC61 might also
be involved in chromatin alignment and mitotic spindle assembly,
possibly by anchoring CEP170 (B€arenz et al., 2018; Pizon et al.,
2020). However, how CCDC61 functions mechanistically is
currently unknown.
Here, we identify CCDC61 as a highly conserved paralog of
SAS6, a key organizer of the central scaffold around which centri-
oles are formed (Leidel et al., 2005). Our crystal structures of
CCDC61 demonstrate that it adopts a SAS6-like fold and forms
oligomers through two homodimerization domains in a similar
way to SAS6: an N-terminal globular head and a parallel coiled-
coil domain. However, instead of the spiral/ring assemblies
observed with SAS6, CCDC61 assembles into linear filaments
with 3-fold, left-handed screw axes in vitro. Further analysis of
CCDC61 reveals that its coiled-coil domainsarecapableofdirectly
interacting with microtubules. Residues important for microtubule
binding are critical for correct localization of the CCDC61 ortholog
VFL3at basal bodiesofChlamydomonasaswell as for ciliary func-
tion in this organism. Based on these findings, we propose that
CCDC61/VFL3 plays a role in scaffolding the assembly of basal
body-associated structures throughout eukaryotes.
RESULTS
CCDC61 Is a Paralog of SAS6
The XRCC4 protein superfamily is constituted by the centriolar
protein SAS6 and the DNA repair proteins XRCC4, XLF, andPAXX. Using a similar computational approach to that used pre-
viously to identify PAXX (Ochi et al., 2015), we identified the cen-
trosomal protein CCDC61 (Andersen et al., 2003) as an addi-
tional candidate member of this superfamily (Figures 1A and
S1A). A phylogenetic analysis of CCDC61 orthologs using PSI-
BLAST (Altschul et al., 1997) revealed that CCDC61 is a highly
conserved protein present in most Eukaryota that possess cen-
trioles, except for flies and nematodes (Figure 1B; Table S1).
Although not present in flies, CCDC61 orthologs are readily iden-
tified in other insects that include bees, beetles, and lice (Table
S1). Secondary structure analyses of CCDC61 orthologs indi-
cate that they all have an N-terminal domain followed by a
discontinuous coiled-coil domain and a low-complexity region,
which includes a putative a helix (a9), predicted to be a coiled
coil, at the C terminus (Figures 1A and S1B). The sequences of
the N-terminal domain and a9 are particularly well conserved
across species, whereas those of the coiled-coil and low-
complexity region are more variable (Figure S1B).
To gain more insight into the domain organization of CCDC61,
we determined the crystal structure of the N-terminal domain of
human CCDC61 (hCCDC611143) at a resolution of 2.6 Å using
X-ray crystallography. The structure was solved by the single
anomalous dispersion method using seleno-methionine-
substituted crystals (Figure 1C; Table 1). As indicated by our bio-
informatics analyses, we found that the protein fold of CCDC61
is remarkably similar to the canonical SAS6/XRCC4-like fold,
which is characterized by the presence of a seven-stranded b
barrel with a helix-turn-helix motif inserted between b4 and 5
(Figures 1C and 1D). CCDC61 has an insertion of an extra a helix
(a3) followed by an unstructured loop between b5 and b6 (Fig-
ures 1C and S1B), which are unique to CCDC61. We conclude
that CCDC61 is a centrosomal protein that constitutes a hitherto
unidentified paralog of the XRCC4 superfamily members.
CCDC61 Forms Higher-Order Assemblies
The asymmetric unit of the hCCDC611143 crystal contained
three copies of protomers that pack tightly against each other
through interface regions whose residues are evolutionary
conserved (Figure S2A; D1 and D2). Remarkably, one observed
CCDC61 homodimer (D1) is highly similar to that formed by the
SAS6 head domain (van Breugel et al., 2011; Kitagawa et al.,
2011) (Figure 2A). The conserved phenylalanine F128 of
hCCDC61 (asterisks in Figures 2A, close up in (i) and S1B,
dark blue arrow in the alignment) makes van der Waals interac-
tions withM70 and V82 lining a hydrophobic pocket of the homo-
dimer partner that is constituted by a2, the b hairpin of b5 and 6,
and the turns before and after a2 (Figure 2A, in (i)). The dimer
interface is further stabilized by an extensive network of salt
bridges and hydrogen bonds, including a b zipper formed by res-
idues found between a1 and a2 (Figures 2A and S2B). In this
network, the conserved aspartate D129 is central to hydrophilic
interactions between two protomers (Figures 2A, in (ii) and S1B,
light blue arrow in the alignment).
To test whether homodimer formation of hCCDC611143
observed in crystallo is also observed in solution, we studied
the oligomeric state of the protein using analytical ultracentrifu-
gation (AUC). This analysis suggests that hCCDC611143 exists
in a monomer-dimer equilibrium with a KD of 170 ± 18 mM (Fig-
ures 2B, S2C, and S2D), suggesting a relatively weak bindingStructure 28, 674–689, June 2, 2020 675
Figure 1. CCDC61 Is an Evolutionally Conserved Protein Paralogous to SAS6
(A) Domain architectures of the XRCC4 superfamily members. Low complexity regions are drawn by lines.
(B) A phylogenetic tree of CCDC61 orthologs. Accession numbers of the corresponding amino acid sequences are provided in Table S1. Numbers are bootstrap
values.
(C) Crystal structure of hCCDC611143. The structure is presented using a cartoon representation and a rainbow color scheme from the N terminus (N; blue) to the
C terminus (C; red). Missing loops are drawn with dotted lines.
(D) Crystal structures of the XRCC4 superfamilymembers SAS6, XRCC4, XLF, and PAXX (PDB: 2Y3W [van Breugel et al., 2011], 1IK9 [Sibanda et al., 2001], 2QM4
[Li et al., 2008], and 3WTD [Ochi et al., 2015], respectively).
See also Figures S1, S7 and Table S1.
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2011; Kitagawa et al., 2011). We next mutated the key residues
F128 and D129 of the SAS6-like homodimerization interface of
CCDC61 (D1 dimer in Figure S2A) to glutamate and alanine,
respectively (hCCDC611143; F128E/D129A) and subjected the pro-
tein to AUC to test whether these residues are important for
CCDC61 dimerization. Indeed, dimer formation was abolished
in this mutant (Figures 2B and S2C), suggesting that this dimer-
ization interface is dominant in solution, while the other
hCCDC611143 homodimer observed in the asymmetric unit of
the crystal (D2 in Figure S2A) appears not to be stable under
the experimental conditions.
Due to their overall structural similarity, we wondered whether
the head domain of CCDC61 could interact with that of SAS6 to
regulate its function. To address this question, we used the re-
combinant head domains of hCCDC611143 and the 15N-labeled
head domain of human SAS61143 and performed a chemical
shift perturbation experiment by nuclear magnetic resonance
(NMR) spectroscopy. Our results shown in Figure S2E did not
reveal an interaction between the two proteins. Thus, we
conclude that the head domain of CCDC61 forms a homodimer
but does not heterodimerize with SAS6.
Besides homodimerization of its head domain, SAS6 contains
a second dimerization domain constituted by a parallel coiled-676 Structure 28, 674–689, June 2, 2020coil domain and, through these two interfaces, is able to
assemble into a 9-fold symmetric ring structure (van Breugel
et al., 2011, 2014; Cottee et al., 2015; Kitagawa et al., 2011)
except forC. elegans (Hilbert et al., 2013), where its SAS6 homo-
log was found in vitro to form spiral assemblies instead. To find
out whether CCDC61 can form a ring in a similar manner to
SAS6, we determined the crystal structure of zebrafish
CCDC61 (residues 1–170; zCCDC611170), which contains
both its head and parts of its coiled-coil domain, by X-ray crys-
tallography at a resolution of 2.9 Å (Figure 2C; Table 1). In the
crystal, zCCDC611170 formed a homo-tetramer mediated by
the head-to-head and the coiled-coil dimer interactions in an
arrangement that would not be compatible with the assembly
of a ring. A filament model of zCCDC611170 suggests that
CCDC61would be able to form protofilaments with a left-handed
3-fold screw axis along the filament, the helical rise of which is
80 Å (Figures 2C and S3A). We also obtained a different crystal
form of zCCDC611170 with a hexagonal instead of an ortho-
rhombic lattice. However, due to poor diffraction quality, we
could not determine the structure of this crystal form.
To further confirm higher-order oligomer formation of
zCCDC611170 in solution, we subjected this construct, as well
as its F129E/D130Amutant that disrupts the head-to-head inter-
action in zCCDC61, to size-exclusion chromatography with
Table 1. Data Collection, Phasing and Refinement Statistics of the CCDC61 Crystal Structures
Crystal
hCCDC611143 zCCDC611168;F129E/D130A zCCDC611170
SeMet (Peak) Native Native
Beamline DLS I02 MRC LMB DLS I03
Wavelength (Å) 0.9792 1.5418 0.9762
Resolution (Å)
Overall 29.68–2.55 44.81–1.97 68.31–2.90
Outer shell 2.66–2.55 2.02–1.97 3.08–2.90
Space group P22121 P212121 C2221
Unit cell parameters
a, b, c (Å) 36.877, 68.222, 180.728 55.36, 76.31, 83.24 93.09, 100.56, 135.76
No. of unique reflections 15,498 25,068 14,498
Completeness (%) 99.1 (99.7)a 98.2 (96.6) 100 (100)
Redundancy 5.0 7.0 5.9
Rmerge
b (%) 7.7 (56.8) 10.2 (86.8) 11.3 (84.9)
<I/s> 14.7 (2.3) 12.6 (2.4) 9.4 (2.0)
CC½ (%) 99.8 (93.2) 99.7 (75.6) 99.9 (84.0)
Phasing method Single anomalous diffraction Molecular replacement Molecular replacement
FOM 0.339 N/A N/A
Overall score 39.02 N/A N/A
Refinement
PDB: 6HXT 6HXV 6HXY
Rcryst
c (highest shell) (%) 20.81 (35.02) 17.32 (23.49) 19.99 (29.73)
Rfree
d (highest shell) (%) 25.60 (41.38) 23.79 (31.77) 25.81 (34.88)
No. of atoms
Protein atoms 2,900 2,559 2,335
Water molecules 66 299 27
Average B factors (Å2) 69.81 34.75 83.16
Ramachandran plot (%)
Favoured 97.2 97.8 96.6
Outliers 0.0 0.3 0.3
Clashscore 7.59 4.30 8.68
MolProbity overall score 1.72 1.25 1.75
RMSD
Bond lengths (Å) 0.004 0.008 0.008
Bond angles () 1.080 1.098 1.203
FOM, figure of merit; RMSD, root-mean-square deviation.
aThe statistics in parentheses are for the highest-resolution shell.
bRmerge = Sh|Ih  <I>|/ShIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of all symmetry-related reflections.
cRcryst = S||Fobs| |Fcalc||/S|Fobs|, Fobs and Fcalc are observed and calculated structure factor amplitudes.
dRfree as for Rcryst using a randomly selected 10% for hCCDC61
1143 and zCCDC611170, and 5% for zCCDC611168;F129E/D130A of the data excluded
from the refinement.
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Articlemulti-angle light scattering analysis. In this experiment, the His6-
lipoyl domain tag of each construct was retained to stabilize the
corresponding proteins at high concentrations. The results
shown in Figure 2D demonstrate that the wild-type, but not the
head-to-head dimerization-deficient mutant, was able to form
higher-order oligomers beyond the coiled-coil-mediated dimer.
Together, these data suggest that CCDC61, like SAS6 (van Breu-
gel et al., 2011, 2014; Kitagawa et al., 2011), is able to self-asso-
ciate into ordered macromolecular assemblies.
Comparison of the structures of zCCDC61, SAS6 (Leishmania
major [lmSAS6]), and Caenorhabditis elegans (ceSAS6) and hu-man XRCC4/XLF by superposition of their head domains
showed that the difference between the exact higher-order as-
semblies formed by these proteins originates from (1) altered
relative orientation angles between their head domains and (2)
altered relative orientation angles between the head and
coiled-coil domains (Figures S3A and S3B). When defining as z
axis (z) the rotation axis required to bring the second head do-
mains of zCCDC61 and lmSAS6 into superposition (Figure S3B,
top panel), the corresponding rotation axis between the head do-
mains of zCCDC61 and ceSAS6 also corresponds to z, whereas
that between zCCDC61 and hXRCC4/XLF is about 10 offStructure 28, 674–689, June 2, 2020 677
(legend on next page)
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Articlerelative to z (Figure S3B, top and lower left panels). In compari-
son with the relative angle between the head and coiled-coil
domain of lmSAS6, the corresponding angle of the other
XRCC4 superfamily members is also altered: The coiled-coil
domain orientation of zCCDC61 and hXRCC4 deviate in the
opposite direction to those of ceSAS6 and hXLF (Figure S3B,
lower right panel). Previous observations of structures of SAS6
suggest that the relative orientation angle between the head
and coiled-coil domains in particular determines the symmetry
of the resulting filaments (Hilbert et al., 2013). Since both head-
to-head and head-to-coiled-coil orientation angles appear to
be able to change independently from each other, a confirmation
of this hypothesis will require further structural information on the
superfamily members. Nevertheless, we conclude that two
separate dimerization domains of the XRCC4 superfamily pro-
teins allow them to form filaments with different symmetries
and helical parameters through mutations of residues involved
in the head-to-head and head-to-coiled-coil interactions.
The Coiled-Coil Domain of CCDC61 Binds to
Microtubules
Next, we overexpressed GFP-hCCDC61 in human RPE-1 cells
and performed a fluorescence-imaging experiment to better un-
derstand the behavior of full-length CCDC61. The majority of the
protein-formed clusters and 25% of GFP-hCCDC61-express-
ing cells showed filament-like structures in the cytoplasmic re-
gion (Figure 3A), although the extent and type of cluster forma-
tion by GFP-hCCDC61 varied widely among cells perhaps due
to differences in expression levels. We hypothesized that the
observed filament formation in vivo might be mediated by
head-to-head dimer formation of CCDC61 as in our crystal struc-
ture (Figure 2A). However, when we disabled head-to-head
dimer formation using the GFP-hCCDC61F128E/D129A mutant,
we still observed a similar variety of localization patterns
compared with the wild-type experiment (Figure 3A). Some of
the hCCDC61 filaments formed in vivo upon overexpression
were reminiscent of cytoplasmic microtubules. Immunofluores-
cence experiments against GFP-hCCDC61 and microtubules
in RPE-1 cells indeed showed colocalization between most,
but not all, of the observed GFP-hCCDC61 filaments and micro-
tubules (Figures 3B and S4A). Similar observations were made
when we overexpressed the GFP-hCCDC61F128E/D129A mutant
(Figures 3B and S4A).
The relative proportion of GFP-hCCDC61 filament- or cluster-
forming cells was largely unchanged when the microtubule-de-
stabilizing agent nocodazole or themicrotubule-stabilizing agentFigure 2. CCDC61 Forms Linear Filaments via Homodimerization Med
(A) Crystal structure of the head-to-head homodimer of hCCDC611143. Missing
indicated by (i) and (ii), of which magnified views are shown in the square boxes o
panel (ii) indicate hydrogen bonds. Head-to-head dimers of SAS6 and XRCC4/XLF
the bottom.
(B) AUC results showing that hCCDC611143 forms homodimers in solution.
(C) Crystal structure of the zCCDC611170 tetramer. On the right, straight arrows i
arrows is 120.
(D) CCDC61 forms higher-order oligomers in solution. Size-exclusion chromatogra
and His6-lipoyl-zCCDC61
1170; F129E/D130A (blue) using a Superdex S200 column
were 1, 6.5, and 65 mg/ml (lightest to darkest red, respectively) and 1, 6.8, and
refractive index values of each chromatography profile were normalized to 0 and
See also Figures S2 and S3.taxol (Figure S4B) were added to cells, indicating that CCDC61
bound microtubules might be protected against the action of
microtubule poisons and that the exchange rate between the
different CCDC61 pools might be low. In agreement, live cell im-
aging of RPE-1 cells showed that GFP-hCCDC61 filaments per-
sisted in the presence of 5 mM nocodazole over the course of 3 h
(Figure S4C).
We speculated that the coiled-coil and/or the C-terminal re-
gions of hCCDC61 are responsible for its microtubule associa-
tion. To test this hypothesis, we overexpressed either the
coiled-coil domain (144–287) or the C-terminal region (288–
512) of hCCDC61 as GFP-tagged constructs in RPE-1 cells
and carried out immunofluorescence experiments. The coiled-
coil domain construct was fused to an NES to avoid its mis-local-
ization to the nucleus. Our results indeed showed that both the
coiled-coil and C-terminal regions of CCDC61 colocalize with
microtubules (Figures 3B and S4A).
Since microtubule association in cells might indicate microtu-
bule binding by CCDC61, we sought to perform a direct binding
assay to address this question. To this end, we purified the
hCCDC61 head domain as well as its coiled-coil and its C-termi-
nal region as recombinant proteins and performed microtubule
co-pelleting assays using taxol-stabilized microtubules in vitro.
To stabilize the coiled-coil domain of hCCDC61, we fused it to
the C terminus of the DNA repair protein PAXX (residues 1–
137) whose head domain is structurally similar to that of
CCDC61 but does not dimerize (Ochi et al., 2015). Our results
suggest that both coiled-coil and C-terminal domain of
CCDC61 are indeed able to directly bind to microtubules
in vitro (P (pellet) in Figure 3C), whereas the head domain is un-
able to do so and remains in the supernatant fraction (S (super-
natant) in Figure 3C).
Positively charged residues of microtubule-associated pro-
teins frequently play a role in microtubule binding (Cooper and
Wordeman, 2009). Intriguingly, the coiled-coil domain of
hCCDC61 (residue 144–287; a4–7) has an overall positive charge
(theoretical pI 10.5). To identify residues involved in microtu-
bule binding by CCDC61, we mutated five conserved positively
charged residues in a7 (K259, R263, R266, R268, and K270, Fig-
ure S1B, red arrows) and repeated the microtubule co-pelleting
assay. Mutation of these residues largely abolished the microtu-
bule binding activity of hCCDC61 (Figure S4D) without affecting
the overall structure of CCDC61 or its general ability to form olig-
omers (Figures S4E and S4F), despite some destabilization of
the mutated coiled-coil domain on its own compared with the
corresponding wild-type construct in vitro (Figure S4F). Theiated by the Head and Coiled-Coil Domains
loops are drawn with dotted lines. Key residues of the interaction interface are
n the right. Asterisk indicates the locations of the F128 residues. Dotted lines in
(PDB: 2Y3V [van Breugel et al., 2011] and 3W03 [Wu et al., 2011]) are shown at
ndicate the N-to-C direction of the coiled-coil domains. The angle between the
phywithmulti-angle light scattering analysis of His6-lipoyl-zCCDC61
1170 (red)
at room temperature. Protein concentrations (before injection onto the column)
73 mg/ml (lightest to darkest blue, respectively). The minimum and maximum
1, respectively.
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Figure 3. CCDC61 Binds Microtubules
(A) Fluorescent images of RPE-1 cells, transiently overexpressing GFP-hCCDC61 or hCCDC61F128E/D129A, showing the different CCDC61 localization patterns
observed under these conditions. Bar graphs show the percentage of GFP-positive cells containing clusters-only ‘‘C’’ versus filament-containing cells ‘‘F’’ (n =
279 for GFP-hCCDC61 and n = 468 for GFP-hCCDC61F128E/D129A counted from three biological replicates). Error bars are standard deviations. Positions of blow-
up images labeled with 1 (filament-containing cell) and 2 (cluster-only cell) are indicated with white-dotted squares in the top panels. Scale bars, 20 mm.
(B) Transiently overexpressed hCCDC61 colocalizes with microtubules in cells. Immunofluorescent images of RPE-1 cells transiently overexpressing GFP-
hCCDC61, GFP-hCCDC61F128E/D129A, GFP-hCCDC61144287NES, and GFP-hCCDC61288512. Anti-GFP staining is shown in green, microtubule staining in red.
Magnified views of the regions indicated by the white-dotted squares in the merged images are shown either below (GFP-hCCDC61 and GFP-hCCDC61F128E/
D129A) or as insets (GFP-hCCDC61144287NES andGFP-hCCDC61288512). Displayed are representative images acquired from a total of 14, 8, 10, and 11 different
RPE-1 cells for GFP-hCCDC61, GFP-hCCDC61F128E/D129A, GFP-hCCDC61144287NES, and GFP-hCCDC61288512, respectively. Scale bars, 10 mm.
(legend continued on next page)
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hCCDC61 might interact with the negatively charged residues
of the tubulin C termini. To test this, we removed the C-terminal
tails of tubulin from taxol-stabilized microtubules using the pro-
tease subtilisin (Serrano et al., 1984) (Figure S4G) and repeated
the microtubule co-pelleting assay. The result showed that the
coiled-coil domain of CCDC61 indeed mainly interacts with the
tubulin C termini (Figure S4H). Intriguingly, upon overexpression
of the 5E mutant of GFP-hCCDC61 in RPE-1 cells, we did not
observe CCDC61 filament formation (Figure S4I), while
CCDC61 clusters were still observed. This indicates that in vivo
and in the full-length context, the a4–7 part of CCDC61 com-
prises the dominant microtubule binding activity in CCDC61
and that filament formation of CCDC61 is largely mediated by
its microtubule binding.
We also mixed the PAXX-stabilized a4–7 coiled-coil domain of
hCCDC61 with taxol-stabilized microtubules and subjected the
mixture to electron microscopic analysis using negative staining.
The micrograph shown in Figure 3D demonstrates that microtu-
bules were decorated with hCCDC61 while this decoration was
not observed when we used the equivalent construct carrying
the 5E mutation (average widths of microtubules: 40.98 ±
2.55 nm [mean ± standard deviation] and 33.97 ± 1.32 nm,
respectively [Figure 3E]). We note that the average width of mi-
crotubules in the presence of the 5E mutant seems to be larger
than the canonical diameter of microtubules (24 nm). However,
this might be due to the negative staining of microtubules on car-
bon-coated electronmicroscopic grids as similar, widermicrotu-
bule widths also have been observed by others (Reid et al., 2017;
Shibata et al., 2012). Together, these results suggest that
CCDC61 primarily binds to microtubules by engaging the C-ter-
minal tails of tubulin via conserved positively charged residues of
a7 of CCDC61.
CCDC61 Localizes to Basal Bodies
In the ciliate protist Paramecium tetraurelia, previous studies
have demonstrated that CCDC61 localizes to basal body-asso-
ciated substructures, such as rootlets or striated fibers (Ben-
gueddach et al., 2017). To find out whether hCCCD61 would
also be found associated with basal bodies in multicellular or-
ganisms, we checked the distribution of CCDC61 in multiciliated
epithelial cells of Xenopus laevis embryos expressing Xenopus
CCDC61 (xCCDC61) fused to the N terminus of RFP. Three-color
imaging of xCCDC61-RFP, Centrin2-BFP (marking the distal
centriole region) and Clamp-GFP (marking the rootlet) in these
multiciliated frog embryos demonstrated that, like its unicellular
orthologs, xCCDC61 associates with the proximal part of basal
bodies in a polarized manner that is close to, but distinct from
rootlets (Figure 4A). We also performed immunofluorescent im-(C) Coiled-coil and C-terminal regions of hCCDC61 bindmicrotubules in vitro. Coo
microtubules with the head domain (1–143), PAXX-fused coiled-coil domain (14
pernatant and pellet fraction, respectively.
(D) The coiled-coil domain of hCCDC61 directly binds microtubules. Negative-st
PAXX-hCCDC61144287 that is not observed with the corresponding 5E mutant
magnified panels (right), respectively.
(E) Quantification of the widths of microtubules decorated by PAXX-hCCDC6114
different positions of ten microtubules were measured for each construct. Each p
represents a measured width at each position. Error bars (standard deviations fr
See also Figure S4.aging of GFP-hCCDC61 overexpressed in RPE-1 cells under
serum-starved conditions in which these cells form a single,
non-motile primary cilium. This analysis showed that hCCDC61
can also localize to the periphery of human basal bodies (Fig-
ure 4B). To investigate the function of hCCDC61 in this cell
line, we generated hCCDC61-deficient RPE-1 cells using
CRISPR/Cas9 (Figure S5A). Although we did not observe
obvious defects in proliferation, cell-cycle progression and
centrosome or centriole numbers (Figures S5B–S5D), we
observed a delay in the formation of primary cilia both in these
hCCDC61-deficient RPE-1 cells (Figure 4C) and also in RPE-1
cells depleted of hCCDC61 by RNA interference (Figure S5E).
The delay in cilia formation that is observed in hCCDC61-defi-
cient cells could potentially impact developmental processes.
However, normal-looking cilia assemble eventually in RPE-1
cells, which suggests that hCCDC61 plays a role in ciliogenesis
but is not essential for the generation of primary cilia. Together,
these results suggest that the localization of CCDC61 to basal
bodies is evolutionarily conserved.
Characterization of Chlamydomonas Strains Carrying
Mutations in the CCDC61 Ortholog VFL3
CCDC61 orthologs play an important role in the functioning of
motile cilia in different model organisms (Azimzadeh et al.,
2012; Bengueddach et al., 2017; Wright et al., 1983). We
wondered whether the filament-forming/microtubule binding ac-
tivity of CCDC61 would be functionally important in this respect.
To answer this question, we used Chlamydomonas as a model
organism because strains containing defective VFL3 (its
CCDC61 ortholog) are available and the mutant phenotypes
have been well characterized (Hoops et al., 1984; Keller et al.,
2010; Marshall et al., 2001; Wright et al., 1983). Furthermore,
VFL3 shares 36% sequence identity with hCCDC61 and key res-
idues involved in head-to-head interaction and microtubule
binding are conserved (Figure S1B, blue and red arrows).
Through Sanger sequencing, we identified a nonsense mutation
(AAG to TAG) in the VFL3 gene in the original mutant, which we
named vfl3-1. The nonsensemutation (K497X; Figure S1B, green
arrow) is found in exon 8. We also obtained an insertion mutant,
LMJ.RY0402.091002, which has an insertion of an exogenous
DNA cassette that confers paromomycin resistance, in intron 7
of VFL3, from the Chlamydomonas CLiP mutant library (Li
et al., 2016). In 20 tetrads of this insertional mutant crossed to
wild-type, we observed complete co-segregation of the paromo-
mycin resistance phenotype and the Vfl phenotype. Therefore,
we considered this insertion mutant a second allele of vfl3 and
renamed it vfl3-2.
In both mutant alleles, we quantitated the Vfl phenotype. We
observed that in an asynchronous culture that 7% and 6% ofmassie-stained SDS-PAGE gel showing a co-pelleting assay of taxol-stabilized
4–287), or the C-terminal region (288–512) of hCCDC61. S and P indicate su-
ain EM micrographs of microtubules that show their decoration with a layer of
of CCDC61. Scale bars, 200 and 50 nm in the overview panels (left) and the
4287 or in the presence of PAXX-hCCDC61144287; 5E from (D). Widths of five
oint (blue for PAXX-hCCDC61144287 and green for PAXX-hCCDC61144287; 5E)
om the mean) are shown in black lines with flat arrow ends.
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Figure 4. CCDC61 Associates with Basal Bodies and Plays a Role in Ciliogenesis
(A) xCCDC61 associates with basal bodies and rootlets in multi-ciliated epidermal cells of Xenopus embryos. A fluorescent image of a Xenopus embryo ex-
pressing xCCDC61-RFP (red), the basal body component Centrin2-BFP (blue), and the rootlet component Clamp-GFP (green). Scale bar, 3 mm.
(B) Location of hCCDC61 at the periphery of basal bodies of primary cilia. Immunofluorescent image of an RPE-1 cell transiently overexpressing GFP-hCCDC61.
Co-immunofluorescent staining was performed against GFP (green), basal bodies (g-tubulin, red), and the ciliary axoneme (ARL13B, magenta). Scale bar, 1 mm.
(C) Ciliated cells of control and CCDC61-knockout RPE-1 cells. Immunofluorescent images show representative immunofluorescent images used for quanti-
fications of ciliogenesis of primary cilia. Scale bar, 10 mm. The bar graph shows that ciliogenesis was delayed in the CCDC61 knockout cells. Data shown
correspond to three biological replicates (total cell counts n = 1,181, 1,103, and 1,008 for control, clone 1 and clone 2 cells after 24-h serum starvation
respectively, and n = 1,151, 1,046 and 1,242 for control, clone 1 and clone 2 after 48-h serum starvation, respectively). Percentages are relative to control cells.
Bar graphs show mean ± standard deviation.
See also Figure S5.
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Articlevfl3-1 and -2, respectively, had more than two flagella. This is a
phenotype not seen in any wild-type strains. Moreover, the two
mutants had an increased number of cells with no flagella
(45% and 58%compared with wild-type with 10%) or one flagel-
lum (26% and 15% versus 5% for wild-type) (Figure 5A). By
immunofluorescence experiments (Figure S6A), the wild-type
(CC-124) exhibited normal distal striated fibers (stained with an-
tibodies to centrin, which is found in the distal striated fibers in
Chlamydomonas [Dutcher and O’Toole, 2016]) and biciliated
cells (stained by acetylated a-tubulin), whereas we noted
abnormal striated fibers and abnormal cilia number in the vfl3-
2 mutant strain as reported previously in vfl3-1 (Wright
et al., 1983).
Analysis of the VFL3 transcripts in vfl3-1 revealed that this
mutant contains a full-length transcript (Figure S6B). In vfl3-2,
the VFL3mRNA is truncated and contains only exons 1–7, which
are located upstreamof the insertional cassette (Figure S6B).We
found that transformation of the wild-type VFL3 gene into vfl3-1
restores normal ciliary numbers (Figures 5A; Table 2). To detect682 Structure 28, 674–689, June 2, 2020the VFL3 protein, a 3xHA epitope tag was introduced within
either exon 7 (ex7-HA) or exon 9 (ex9-HA) of VFL3 and both
tagged VFL3 transgenes were integrated into the vfl3-2 strain,
where they gave rise to full-length VFL3 transcripts (Figure S6B).
However, the tagged genes only partially rescued the mutant
phenotype (Figure 5A). The number of cells with zero flagella is
not restored to wild-type levels (p < 0.0001) by a c2 test (Fig-
ure 5A). The transgene did restore the striated fiber phenotype
in vfl3-2 (Figure S6A). Therefore, we confirmed that the pheno-
types of the vfl3 strains are due to the VFL3 gene defects.
The Basic Amino Acids Involved in Microtubule Binding
Are Important for VFL3 Function and Localization
Immunoblots of Chlamydomonas whole-cell extracts from
various transformants that carry either ex7-HA- or ex9-HA-
tagged VFL3 with an anti-HA antibody reveal a single polypep-
tide with the expected size of 85 kDa (Figures S6C and S6D),
which is absent in extracts of wild-type cells (CC-124) (Fig-
ure S6C). Immunofluorescence of NFAPs (nucleoflagellar
Figure 5. Chlamydomonas VFL3 Protein Localizes to Basal Bodies and the Proximal Ends of Flagella
(A) Rescue of abnormal flagella numbers in vfl3 strains by wild-type VFL3. Bar chart showing flagella numbers observed in wild-type strains (CC-124 and CC125),
mutant strains (vfl3-1 and vfl3-2), and the vfl3-1 and vfl3-2 strains expressing VFL3 constructs in Chlamydomonas. The numbers of cells ‘‘n’’ used for calculating
ratio flagella numbers are shown on the right side of the chart. A c2 test was used to determine if the number of cells with zero flagella was significantly different.
NS, not significant; ***p < 0.0001.
(B) Wild-type VFL3 protein localizes to Chlamydomonas basal bodies. In the first column, cells were stained with acetylated a-tubulin (red) for cilia and rootlet
microtubules, anti-HA (green) for UNI2, and anti-GFP (magenta) for VFL3. Scale bar, 4 mm.Magnified views (43) of the basal body regions (white boxes) are shown
on the other three columns. Scale bars, 1 mm.
(C) Localization of VFL3 is affected in the 5Emutant. In the first column, cells were stained with acetylated a-tubulin (red) for cilia and rootlet microtubules, anti-HA
(green) for wild-type and mutant VFL3, and anti-BLD10/CEP135 (magenta). Scale bar, 4 mm. Magnified views (43) of the basal body regions (white boxes) are
shown on the other three columns. Scale bar, 1 mm.
See also Figure S6.
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Articleapparatus) (Wright et al., 1985) in multiple, independent trans-
formants shows that VFL3 (Figures 5B, magenta and 5C, green)
localizes to both the basal bodies (Figures 5B, green and 5C,
magenta). To determine the precise location of VFL3 in the basal
bodies, we co-stained VFL3 with UNI2, a protein that localizes to
the distal end of the basal bodies (Figures 5B; Video S1) (Piasecki
and Silflow, 2009); and BLD10/CEP135, which localizes to the
cartwheel of the basal bodies at their proximal end (Matsuura
et al., 2004) (Figure 5C). Our results suggest that VFL3 does
not overlap completely with either UNI2 or BLD10 and is likely
distributed along the full length of the basal bodies.
We next asked whether filament formation and microtubule
binding of VFL3 are important for its function and localization.
We first generated a strain containing the F126E and D127A mu-
tations in VFL3 (VFL3-FD), which are equivalent to the F128E/
D129A mutation in hCCDC61 that disrupts its head-to-head ho-
modimerization. We transformed the VFL3-FD transgene (un-
tagged or HA tagged [Figure S6D]) into both vfl3-1 and vfl3-2cells, and observed a partial rescue of the mutant phenotype in
the vfl3-1 and vfl3-2 cells, respectively (Figure 5A). The untagged
VFL3 transgene, and the untagged FD mutant transgene are
significantly different from the mutant parent, while the untagged
FD mutant is also significantly different from the strain with the
wild-type transgene (p < 0.0001) based on the number of cells
with zero flagella (Figure 5A) by a c2 test. The HA-tagged FD
mutant was not significantly different from the HA-tagged wild-
type transgene in the vfl3-2 strain. The difference between
tagged and untagged FD mutants might be due to the HA tag
partially interfering with the protein function. About 2% of cells
contain more than two cilia compared with less than 0.1% in
wild-type cells. These data suggest that there is a partial rescue
of the Vfl phenotype by the VFL3-FD transgene. The VFL3-FD-
HA protein localizes to the basal body region (Figure 5C), similar
to what we observed in wild-type VFL3-HA. We also mutated the
five basic amino acids residues (K266, R270, K273, R275, and
R277), whose equivalents in hCCDC61 are involved inStructure 28, 674–689, June 2, 2020 683








vfl3-1 VFL3 875 3
VFL3-FD 316 1 (partial rescued)
VFL3-5E 449 0
vfl3-2 VFL3 666 8















aTransformants are identified by co-transformation with the APHVIII gene
that confers resistance to the antibiotic paromomycin.
ll
Articlemicrotubule binding, to glutamates (VFL3-5E). Co-transforma-
tion of the VFL3-5E transgene into the vfl3-1 and vfl3-2 strains
with the APHVIII gene, which confers resistance to the antibiotic
paromomycin, failed to yield any strains with a rescued pheno-
type in 1,400 drug-resistant transformants (Table 2). To inves-
tigate whether the failure to rescue is caused by an absence of
expression of the transgene or by the 5E mutation, we co-trans-
formed an HA-tagged version of VFL3-5E into vfl3-2 and
screened 200 drug-resistant transformants by immunoblot
and immunofluorescence (Figures 5C and S6D). We obtained a
single transformant that showed expression of the HA-VFL3-
5E protein but the 5E mutant strain was not significantly different
from the mutant vfl3-2 parent (p = 0.68) based on the number of
cells with zero flagella (Figure 5A) by a c2 test (Figure 5A). We
observed accumulation of HA-VFL3-5E around the basal body
region with BLD10/CEP135 (Figure 5C). Thus, our results sug-
gest that the microtubule binding region of VFL3/CCDC61 plays
a critical role in its function and accurate localization in
living cells.
DISCUSSION
Here we provide a detailed structural and biochemical charac-
terization as well as a functional analysis of the centrosomal pro-
tein CCDC61. CCDC61 is a paralog of the centriolar protein
SAS6, forms higher-order oligomers and is capable of binding
microtubules in vitro and in vivo. Furthermore, we demonstrate
that the CCDC61 ortholog in Chlamydomonas, VFL3, localizes
at basal bodies. Our functional studies in cells suggest that
microtubule binding of VFL3/CCDC61 is important for its correct
localization to basal bodies and its function in vivo, whereas its
head-to-head interaction appears not to be critical but plays a
role in ensuring faithful formation of basal bodies in vivo. Collec-
tively, our data suggest that the main function of CCDC61 might684 Structure 28, 674–689, June 2, 2020lie in the organization of basal body-associated structures
(Figure 6).
Our biochemical and structural data unambiguously demon-
strate that CCDC61 belongs to the XRCC4 superfamily of pro-
teins.Members of this superfamily have a centrosomal/centriolar
function (SAS6 [Leidel et al., 2005] and CCDC61 [Andersen et al.,
2003; Wright et al., 1983]) or play crucial roles in the NHEJ DNA
repair pathway (XRCC4 [Li et al., 1995], XLF [Ahnesorg et al.,
2006; Buck et al., 2006] and PAXX [Craxton et al., 2015; Ochi
et al., 2015; Xing et al., 2015]). Their protein architecture consists
of an N-terminal head domain followed by a coiled-coil and
C-terminal low-complexity region. A structure-guided sequence
alignment of the head domains of the human XRCC4 superfamily
members showed that the sequence identities between them are
below 20% (Figures S7A and S7B). However, they share a
conserved sequence motif (Figure S7A, red-dotted rectangle),
which has previously been named the PISA motif (Leidel et al.,
2005). The motif is likely to be critical for the functions of the
XRCC4 superfamily members because homozygous mutations
in this motif in XRCC4, XLF, or SAS6 cause growth defects
(Buck et al., 2006; Khan et al., 2014; Murray et al., 2015). Their
similarity also extends to the ability of the superfamily members
(except for PAXX), to form protofilaments using two dimerization
interfaces provided by the head and the coiled-coil domains.
Head-to-head dimerization in all these cases occurs with a low
binding affinity, suggesting that these proteins need to be en-
riched locally and/or be stabilized by other molecules to effi-
ciently form faithful higher-order assemblies. In agreement with
this, the protein concentration of CCDC61 in HeLa cells appears
to be very low (Bauer et al., 2016). SAS6 assembly, for instance,
is probably aided by its interaction with CEP135 and STIL
(Dzhindzhev et al., 2014; Lin et al., 2013; Ohta et al., 2014),
whereas for the XRCC4/XLF complex this function is exerted
by its associations with DNA ligase IV, Ku70/80 and DNA (Ochi
et al., 2014). Putative CCDC61 binding proteins, such as
CEP170 (B€arenz et al., 2018; Pizon et al., 2020) might play an
equivalent role in CCDC61. Thus, the overarching principles of
higher-order oligomerization and stabilization by other proteins
appears to be conserved among the XRCC4 superfamily mem-
bers. It is worth mentioning that the head domain of hCCDC61
contains a conserved surface area that is not directly involved
in D1 dimer formation as described in Figures 2A and S2A.
Instead, it contributes to the formation of the D2 dimer that we
observed in the asymmetric unit of the hCCDC611143 crystal,
but not in solution (Figures 2B, S2A, and S2C). This surfacemight
be involved in a protein-protein interaction between CCDC61
and another protein. Alternatively, it is possible that the D2 dimer
exists in vivo under high local concentrations and that it might
facilitate formation of CCDC61 filament bundles. Indeed, when
we superposed two CCDC61 filaments onto the D2 structure,
we found that these filaments do not clash strongly with each
other (Figure S7C).
Our phylogenetic analysis demonstrates the presence of
CCDC61 in most ciliated eukaryotes, except for flies and nema-
todes. Interestingly, the conservation pattern of CCDC61 (Table
S1) is very similar to those of d- and ε-tubulins (Hodges et al.,
2010), which are important for centriolar doublet and triplet
microtubule formation (Dutcher et al., 2002; Dutcher and Tra-
buco, 1998; Wang et al., 2017). However, our data argue against
Figure 6. Model of the Role of CCDC61 in Ciliary Function (in Chlamydomonas)
CCDC61 localizes to the basal body and forms filaments that bind to centriolar and/or non-centriolar microtubules. This facilitates striated fiber formation and the
correct formation of basal body-associated structures, and therefore, results in the correct cilium number. A CCDC61 mutant that does not bind microtubules
(MT-binding null mutant) still localizes to the basal body region. However, the mutant is incapable of facilitating striated fiber formation, leads to incorrect for-
mation of basal body-associated structures, and therefore causes abnormal cilium numbers.
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Articlea central role of CCDC61 in centriole/centrosome duplication in
human cells (Figures S5B–S5D). These results agree with find-
ings in the flatworm S. mediterranea (Azimzadeh et al., 2012),
but contrast with reports from the unicellular Chlamydomonas
(Marshall et al., 2001) and Paramecium (Bengueddach et al.,
2017). The difference between these studies possibly stems
from the fact that centrioles are duplicated as basal bodies in
these organisms, whereas they are duplicated through the cen-
trosomal or deuterosomal pathway in humans and planaria.
Thus, CCDC61 itself might not be part of the core centriole dupli-
cation machinery in these unicellular organisms, but rather be
important for the maintenance of the basal body-associated ar-
chitectures that are needed for the faithful recruitment of this
duplication machinery to probasal bodies.
Consistent with a role of CCDC61 in basal body function, we
observed localization of CCDC61 at basal bodies of primary cilia
of human RPE-1 cells, motile cilia in green algae, and motile cilia
of multiciliated cells of frog embryos (Figures 4A, 4B, 5B, and
5C). Our data, as well as evidence from other systems in which
CCDC61 has been studied, suggest that the main function of
CCDC61 is related to basal body function in cells with motile cilia.
In themotile ciliateParamecium, CCDC61 localizes at the interface
between basal bodies and striated rootlets and is important for
their organization (Bengueddach et al., 2017). These basal body-
associated structures play a role in basal body positioning at the
cell cortex and in probasal body assembly (Hoops et al., 1984). A
specific role of CCDC61 in the anchoring of basal bodies in multi-
ciliated cells is also suggested by experiments in the planarian
S.mediterranea. Planariamovebyglidingona ventral arrayofmul-
ticiliated cells (Azimzadeh and Basquin, 2016). Knockdown of
CCDC61 inS.mediterraneawas found to result in an abnormal di-
rection of locomotion (Azimzadeh et al., 2012) due to basal body
mis-orientations caused by a failure to generate basal feet and
ciliary rootlets correctly (Basquin et al., 2019).This notion is in agreement with previous studies on the Chla-
mydomonas vfl3-1 strain that suggest that VFL3 is crucial for the
faithful organization of proximal and distal striated fibers as well
as rootlet microtubules (Hoops et al., 1984; Wright et al., 1983).
We also confirmed this using the insertional mutant strain (vfl3-
2). Interestingly, the vfl3-1 strain carries a premature stop codon
after K497, which would retain the head and coiled-coil domains
of VFL3 but not a9. Similarly, our transcript analysis suggests
that the vfl3-2 strain may carry a truncated protein that retains
the first 406 amino acids of VFL3, 22 amino acids downstream
of the a8 helix. Thus, this could be indicative of a crucial role of
a9 in VFL3 function, given the mutant phenotype in both strains.
However, since we could not obtain reliable antibodies that
detect VFL3, we cannot exclude the possibility that the truncated
VFL3 gene product is destabilized in these strains explaining the
observed phenotype.
Although our crystal structures of CCDC61 fragments
in vitro suggest that CCDC61 forms filaments (Figure 2C),
we could not visualize these in vivo. However, a VFL3/
CCDC61 allele with a disabled head-to-head dimerization
(VFL3-FD) was unable to completely rescue the Vfl pheno-
type (Figure 5A) in Chlamydomonas, arguing for a functional
role of this interface. Furthermore, since both vfl3-1 and
vfl3-2 strains retain intact exons 1–7 of VFL3 (residue range
1–406), a heterodimer between the putative truncated VFL3
and the rescue construct might form and be partially func-
tional, potentially accounting for the weak phenotype
observed in the VFL3-FD strain. Intriguingly, in the filaments
formed by CCDC61 in vitro, the distance between the projec-
ting coiled-coil domains of CCDC61 that point in the same di-
rection is about 24 nm, which corresponds to three times the
8-nm repeat of tubulin dimers in microtubules (Figure 2C). This
periodicity might facilitate microtubule interaction by the
CCDC61 coiled-coil domain.Structure 28, 674–689, June 2, 2020 685
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ArticleDespite the weak phenotype observed in the VFL3-FD strain,
we speculate that the ability of CCDC61/VFL3 to form higher-or-
der assemblies might aid scaffold formation of the protein
through which basal body-associated substructures are
anchored or helped to stay in place under the mechanical
stresses acting on motile cilia (Figure 6). CCDC61/VFL3 might
interact with a centrosomal and basal body-specific protein
that is yet to be identified, and scaffold the protein with microtu-
bules to construct regularly aligned basal body-associated
structures. Two groups recently proposed that CCDC61 inter-
acts with CEP170 and might play a role in the subdistal
appendage function of centrioles (B€arenz et al., 2018; Pizon
et al., 2020). While our manuscript was under review, Pizon
and colleagues also reported CCDC61 association with microtu-
bules (Pizon et al., 2020), in agreement with our data.
Our study also raises several questions, particularly, whether,
in vivo, CCDC61 forms protofilaments as observed in crystallo
and, if so, what their exact role is. How does microtubule binding
of CCDC61 assist in the assembly and organization of basal
body-associated structures? Further research efforts are
required to elucidate the exact function and themolecular mech-
anisms of CCDC61 that underlie the biogenesis of these
structures.STAR+METHODS
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hCCDC61 Synthesized by GenScript UniProt: Q9Y6R9
zCCDC61 Source BioScience IMAGE ID: 7406569. UniProt: Q08CF3
xCCDC61 Synthesized by
Thermo Fisher Scientific
NCBI accession number: XP_018084688.1
PAXX Ochi et al., 2015 N/A
GFP nanobody Synthesized by GenScript N/A
(Continued on next page)
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REAGENT or RESOURCE Source Identifier
pGAT3-hCCDC611-143 this paper N/A
pGAT3-hCCDC611-143; F128E/D129A this paper N/A
pSKB2LNB-zCCDC611-168; F129E/D130A this paper N/A
Lipo-zCCDC611-170 this paper N/A
Lipo-zCCDC611-170; F129E/D130A this paper N/A
pSKB2LNB-zCCDC61146-280 this paper N/A
pSKB2LNB-zCCDC61146-280; 5E this paper N/A
pSKB2LNB-PAXX1-137-hCCDC61144-287 this paper N/A
pSKB2LNB-PAXX1-137-hCCDC61144-287; 5E this paper N/A
pSKB2LNB-hSAS61-143 this paper N/A
pHAT5-GFP-nonobody this paper N/A
short-VFL3-TOPO this paper N/A
WT-VFL3-TOPO this paper N/A
pEGFP-C1-hCCDC61 this paper N/A
pEGFP-C1-hCCDC61F128E/D129A this paper N/A
pEGFP-C1-hCCDC61144-287-NES this paper N/A
pEGFP-C1-hCCDC61288-512 this paper N/A
pEGFP-C1-hCCDC611-457; F128E/D128A this paper N/A
pEGFP-C1-hCCDC611-457; F128E/D129A/5E this paper N/A
pcDNA3-3xHA-hCCDC611-457; F128E/D128A this paper N/A
pcDNA3-3xHA-hCCDC611-457; F128E/D129A/5E this paper N/A
pENTR-D-TOPO-xCCDC61 this paper N/A
pCS2+-xCCDC61-RFP this paper N/A
pCS2+-Centrin2-BFP this paper N/A
pCS2+-Clamp-GFP Park et al., 2008 N/A
AIO-GFP-hCCDC61 this paper N/A
pGAT3 Per€anen et al., 1996 Addgene: 112589
pHAT4 Per€anen et al., 1996 Addgene: 112585
pHAT5 Per€anen et al., 1996 Addgene: 112586
pSKB2LNB Fekairi et al., 2009 N/A
pcEGFP-C1 Clontech Catalog # 6084-1
pcDNA3 Invitrogen Catalog # A-150228
AIO-GFP Chiang et al., 2016 Addgene: 74119
pENTR-D-TOPO Thermo Fisher Scientific Catalog # K240020
pCR2.1-TOPO Thermo Fisher Scientific Catalog # K455001
Software and Algorithms
Jpred Drozdetskiy et al., 2015 http://www.compbio.dundee.ac.uk/jpred/
BackPhyre Kelly and Sternberg, 2009 http://www.sbg.bio.ic.ac.uk/phyre2/
html/page.cgi?id=index
HHPred Söding et al., 2005 https://toolkit.tuebingen.mpg.de/
tools/hhpred
PSI-BLAST Altschul et al., 1997 https://blast.ncbi.nlm.nih.gov/Blast.cgi?
CMD=Web&PAGE=Proteins&PROGRAM=
blastp&RUN_PSIBLAST=on
MUSCLE Edgar, 2004 https://www.drive5.com/muscle/
BOXSHADE N/A https://embnet.vital-it.ch/software/
BOX_form.html
SIAS server N/A http://imed.med.ucm.es/Tools/sias.html
SeaView Gouy et al., 2010 http://doua.prabi.fr/software/seaview
PhyML Guindon et al., 2010 http://www.atgc-montpellier.fr/phyml/
(Continued on next page)
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REAGENT or RESOURCE Source Identifier
FigTree N/A http://tree.bio.ed.ac.uk/software/figtree/
Modeller Sali and Blundell, 1993 https://salilab.org/modeller/
TopMatch Sippl and Wiederstein, 2012 https://topmatch.services.came.sbg.ac.at/
XDS Kabsch, 2010 http://xds.mpimf-heidelberg.mpg.de/
CCP4 program suite Winn et al., 2011 https://www.ccp4.ac.uk/ccp4i_main.php
iMOSFLM Battye et al., 2011 Run from CCP4 program suite
Aimless Evans, 2011 Run from CCP4 program suite
PHENIX suite Adams et al., 2010 https://www.phenix-online.org/
MolProbity Run from PHENIX suite
Coot Emsley et al., 2010 https://www2.mrc-lmb.cam.ac.uk/
personal/pemsley/coot/
PyMOL N/A https://pymol.org/2/
Consurf Glaser et al., 2003 https://consurf.tau.ac.il/
SEDFIT Schuck, 2003 http://www.analyticalultracentrifugation.
com/sedfit.htm




SEDPHAT Schuck, 2003 http://www.analyticalultracentrifugation.com/
sedphat/default.htm
GUSSI Brautigam, 2015 http://biophysics.swmed.edu/
MBR/software.html
Topspin Bruker N/A
SPARKY T. D. Goddard and D. G. Kneller,
University of California
https://www.cgl.ucsf.edu/home/sparky/
CRISPR DESIGN Hsu et al., 2013 No longer available
LAS X Leica N/A
Zen Zeiss N/A
Volocity Perkin Elmer N/A
Fiji Schindelin et al., 2012 https://imagej.net/Fiji/Downloads
Photoshop Adobe N/A
Huygens Professional Scientific Volume Imaging N/A
FCS EXPRESS 6 De Novo Software N/A
Prism GraphPad N/A
Social Science Statistics N/A https://www.socscistatistics.com/
tests/chisquare/
Other
GSTrap FF 16/10 GE Healthcare Life Sciences Catalog # 28936550
GSTrap HP GE Healthcare Life Sciences Catalog # 17528202
HisTrap HP GE Healthcare Life Sciences Catalog # 17524801
HisTrap FF GE Healthcare Life Sciences Catalog # 17525501
HiTrap Q HP GE Healthcare Life Sciences Catalog # 17115401
HiTrap Q FF GE Healthcare Life Sciences Catalog # 17515601
HiTrap Heparin HP GE Healthcare Life Sciences Catalog # 17040701
PD-10 desalting column GE Healthcare Life Sciences Catalog # 17085101
Superdex 75 16/600 GE Healthcare Life Sciences Catalog # 28989333
Superdex S200 10/300 GE Healthcare Life Sciences Catalog # 17517501
16 Chambered cover glass Grace Bio-Labs Catalog # 112358
Multi-spot slide Thermo Fisher Scientific Catalog # 9991090
400 mesh carbon-coated copper grids Electron Microscopy Sciences Catalog # CF400-Cu-50
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Takashi
Ochi (T.Ochi@leeds.ac.uk).
Materials Availability
All unique/stable reagents generated in this study are available from the Lead Contact without restriction.
Data and Code Availability
Coordinates and structure factors of crystal structures that are presented in this paper are available in the Protein Data Bank (PDB
codes: 6HXT (hCCDC611-143), 6HXV (zCCDC611-168; F129E/D130A) and 6HXY (zCCDC611-170)).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Cell Culture
All cells were grown in 37 C with 5% CO2. HEK293T cells (sex: female) were grown in D-MEM, GlutaMAX (Thermo Fisher Scientific)
supplied with 10% FBS. RPE-1 cells (sex: female) were grown in D-MEM/F-12 supplied, GlutaMAX, sodium carbonate (Thermo
Fisher Scientific) supplied with 0, 0.5 or 10%FBS, and 100 unit of penicillin and 100 mg/ml of streptomycin. RPE-1 and RPE-1 PuroKO
that used in this study have been authenticated by STR profiling. STR profiling of HEK293T revealed a 68%match between our cells
and the ATCC standard; this suggest a drift in our stock (which is fairly common for HEK293T), and thus these cells were used only for
protein production (Figure S4E) and not for functional assays. In addition to these cell lines, RPE-1 PuroKO/CCDC61KO cells have
been confirmed as mycoplasma free.
Xenopus Embryo Culture
Xenopus embryo were prepared as described previously (Hörmanseder et al., 2017). Briefly, mature Xenopus laevis males and fe-
males were obtained from Nasco. Females were injected with 50 units pregnant mare serum gonadotropin 3 days in advance and
500 units human chorionic gonadotropin 1 day in advance in the dorsal lymph sack to induce natural ovulation. Eggs were laid in
a 1x MMR buffer (5mM HEPES pH 7.8, 100mM NaCl, 2mM KCl, 1mM MgSO4, 2mM CaCl2, 0.1mM EDTA). Xenopus embryos
were cultured at 14C in the 0.1x MMR until they reached stage 27/28. Our work with Xenopus laevis is covered under the Home
Office Project License PPL 70/8591 and frog husbandry and all experiments were performed according to the relevant regulatory
standard.
Chlamydomonas Culture
Chlamydomonas reinhardtii strains were maintained on solid Sager and Granick (R) growth medium at 25C. For electroporation,
Chlamydomonas cells were grown in Tris-acetate phosphate (TAP) medium at 25C under constant illumination till the cell density
reached 13 x 106 cells/ml. Transformants were selected on modified TAP medium (0.75 ml of Glacial acetic acid/1L TAP) supplied
with 10 mg/ml hygromycin at 25C. For immunofluorescence, Chlamydomonas cells were first resuspended in liquid M-N/5 medium
for 4 hours and treated with autolysin for 30 min at 25C before fixation of cells.
Bacterial Cell Culture
BL21(DE2) (New England Biolabs), C41(DE3) (Miroux andWalker, 1996) or Rosetta cells (a kind gift of Dr. John Kilmartin, MRC LMB,
Cambridge, UK) were grown in LB or 2xTY media and used for protein expression and purification.
METHOD DETAILS
Amino-acid Sequence Analysis
As summarized in Figure S1A, hCCDC61 was identified as a paralog of XRCC4 using residue 1-213 of chain A of the crystal structure
of XRCC4 (PDB code: 1IK9 (Sibanda et al., 2001)) as an input for the BackPhyre webserver (Kelley and Sternberg, 2009). Candidate
proteins fromBackPhyre whose alignments with XRCC4 covered its head domain were further analysed using HHpred (Söding et al.,
2005) and JPred (Cole et al., 2008). Criteria to be defined as XRCC4-like proteins were: a) the candidates were predicted as XRCC4-
superfamily members using HHPred and b) they have secondary-structure profiles that are similar to these family members.
Orthologs of hCCDC61 (UniProt accession number: Q9Y6R9) were identified using PSI-BLAST (Altschul et al., 1997) and aligned
usingMUSCLE (Edgar, 2004) on SeaView (Gouy et al., 2010). A phylogenetic treewas created using the PhyML server (Guindon et al.,
2010) with the default setting and 100 bootstrap replicates, and edited using FigTree (http://tree.bio.ed.ac.uk/software/figtree/). Sec-
ondary structure predictions were carried out using the JPred webserver.
The crystal structure of zebrafish SAS6 (PDB code: 2Y3W (van Breugel et al., 2011)) was used as a template to model a structure of
human SAS6 using Modeller (Sali and Blundell, 1993). This model together with crystal structures of hCCDC61 (from this study),
XRCC4, XLF and PAXX (PDB codes: 1IK9 (Sibanda et al., 2001), 2QM4 (Li et al., 2008) and 3WTD (Ochi et al., 2015) respectively)e5 Structure 28, 674–689.e1–e11, June 2, 2020
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Constructs and Antibodies
The human CCDC61 gene was codon optimized for E. coli and synthesized (GenScript), that of Danio rerio was purchased from
Source BioScience and that of Xenopus laevis was synthesized without codon optimization (Thermo Fisher Scientific). hCCDC61
constructs were PCR amplified and cloned into a pGAT3 (Per€anen et al., 1996) or pSKB2LNB vector (a pET28-derived vector result-
ing in a fusion protein containing a N-terminally, PreScission protease-cleavable His6 tag) (Fekairi et al., 2009) for bacterial expression
and pEGFP-C1 or pcDNA3-3xHA for human expression. NES peptides (LQLPPLERLTLD (Wen et al., 1995)) were added to some of
gfp-hCCDC61 constructs after short linkers (SGSS) by PCR. The zCCDC61 constructs were cloned into pSKB2LNB or a bacterial-
expression plasmid encoding a N-terminal His-tagged lipoyl domain from Bacillus stearothermophilus dihydrolipoamide acetyltrans-
ferase for bacterial expression. The xCcdc61 gene was cloned into pENTR-D-TOPO vector to fuse it to RFP in pCS2+ vectors. Plas-
mids expressing Centrin2 and Clampwere kind gifts fromDr JohnWallingford (Park et al., 2008). TheCentrin2 gene followed by a bfp
gene was cloned into the pCS2+ vector. The plasmid containing the bfp gene was a kind gift from Dr Keith Boyle (MRC LMB). A GFP-
nanobody gene was codon optimized for E.coli and synthesized (GenScript) and cloned into pHAT5 vector (Per€anen et al., 1996).
Site-directed mutagenesis was carried out by PCR using forward and reverse primers encoding mutant amino acids (Table S2).
The4 kbChlamydomonas VFL3 gene, which includes600 bp upstream of the start codon and700 bp downstream of the stop
codon, was amplified by PCR (VFL3-1F and VFL3-7R) using the CloneAmp HiFi Premix (Clontech) and cloned into the pCR2.1-TOPO
vector (Thermo Fisher Scientific). No rescue of vfl3-1was observed with this 8 Kb VFL3-TOPO plasmid (short-VFL3-TOPO), presum-
ably due to short promoter at the 5’ end. Therefore, a3.6 kb fragment upstreamof VFL3, which include the 5’ UTR and part of exon 1
of VFL3, was amplified by PCR (CloneAmp HiFi, VFL3-NotI-F and VFL3-NdeI-R) and cloned into the short-VFL3-TOPO plasmid di-
gested withNotI andNdeI by Infusion HD cloning (Clonetech). This plasmid (WT-VFL3-TOPO) contains3.6 kb upstream of the VFL3
start codon and it rescues the vfl3-1 mutant phenotype.
To generate the 3x HA tagged VFL3 plasmids, a HpaI restriction site was introduced in-frame to either exon 7 or exon 9 via over-
lapping PCR by creating the restriction enzyme site in the primers. For the exon 7-HpaI plasmid, a 1.5 kb fragment was amplified by
primers VFL3-13F-AflII and VFL3-13R-HpaI and a 0.2 kb fragment was amplified by primers VFL3-14F-HpaI and VFL3-14R-SalI from
the short-VFL3-TOPOplasmid. These two fragmentswere gel purified and used as templates in a second round of PCRusing primers
VFL3-13F-AflII and VFL3-14R-SalI for a 1.7 kb fragment. This fragment was digested with AflII and SalI and replaced the correspond-
ing fragment from the short-VFL3-TOPO plasmid. The HA epitope tag was amplified by PCR (exon 7-HpaI-HA-F and R) and cloned
into the HpaI digested plasmid via Infusion HD cloning. For the exon 9-HpaI plasmid, a 0.8 kb fragment was amplified by primers
VFL3-7F and VFL3-15R-HpaI and a 0.4 kb fragment was amplified by primers VFL3-15F-HpaI and VFL3-3R from the short-VFL3-
TOPO plasmid. A second round PCR was used to amplify a 1.2 kb fragment with VFL3-7F and VFL3-3R. This fragment was digested
with SalI and PmlI and replaced the corresponding fragment from the short-VFL3-TOPO plasmid. The HA epitope tag was amplified
by PCR (exon 9-HpaI-HA-F and R) and cloned into the HpaI digested plasmid via Infusion HD cloning. The 3.6 kb upstream frag-
ment described abovewas then introduced the exon 7-HA and exon 9-HA plasmids respectively to create exon 7-HA-VFL3 and exon
9-HA-VFL3 plasmids used in vfl3-2 rescue. A similar strategy was used to introduce a GFP-tag (Fuhrmann et al., 1999) in-frame to
exon 7 of VFL3 at theHpaI site. TheUNI2::HA genewas introduced into the vfl3 strains by crosses so that only one integration site was
present in all of the strains.
Both FD-VFL3 and 5E-VFL3 plasmids were generated by overlapping PCR. For the FD-VFL3 plasmid, a 0.4 kb fragment was ampli-
fied by primers VFL3-8F and VFL3-FD-R and a 0.7 kb fragment was amplified by primers VFL3-FD-F and VFL3-5R from the short-
VFL3-TOPO plasmid. These two fragments were gel purified and used as templates in a second round of PCR using primers VFL3-8F
and VFL3-5R for a 1.1 kb fragment. This fragment was digested with AflII and BbvCI and replaced the corresponding fragment from
the exon 7-HA-VFL3 plasmid. For the 5E-VFL3 plasmid, a 0.6 kb fragment was amplified by VFL3-2F and VFL3-5E-R and a 1.1 kb
fragment was amplified by primers VFL3-5E-F and VFL3-6R from the short-VFL3-TOPO plasmid. These two fragments were gel pu-
rified and used as templates in a second round of PCR using primers VFL3-2F and VFL3-6R for a 1.7 kb fragment. This fragment was
digestedwithBbvCI andSalI and replaced the corresponding fragment from the exon 7-HA-VFL3 plasmid. All primers used to amplify
Chlamydomonas VFL3 are listed in Table S3.
The following primary antibodies were used: ARL13B (Proteintech, 17711-1-AP) 1/500 for immunofluorescent staining (IF),
a-tubulin (Sigma-Aldrich, T9026) 1/500 for IF, acetylated a-tubulin antibody (Abcam, ab179484) 1/500 for IF, g-tubulin (Sigma-Al-
drich, T6557) 1/1000 for IF, GFP (Abcam, ab13970 or Thermo Fisher Scientific, 3E6, A11120) 1/2000 or 1/250 for IF, HA (a kind
gift from Dr. Manu Hedge or Roche, 3F10, 11867423001) 1/200 for IF or 1/3000 for WB, centrin (a kind gift from Dr. Jeffrey L. Salis-
bury) 1/250 for IF, and Centrin 3 (Abnova, H00001070-M01) 1/500 for IF. Secondary antibodies used include Alexa-488-conjugated
Donkey anti-rabbit (Thermo Fisher Scientific, A21206) 1/2000 for IF, Alexa-488-conjugated Goat anti-chicken (Thermo Fisher Scien-
tific, A11039) 1/2000 for IF, Alexa-488-conjugated goat anti-rat antibody (Invitrogen, API83P) 1/500 for IF, Alexa-488-conjugated
goat anti-mouse antibody (Molecular probes, A11001) 1/500 for IF, Alexa-555-conjugated Goat anti-mouse (Thermo Fisher Scien-
tific, A21422) 1/2000 for IF, Alexa 594-conjugated chicken anti-mouse antibody (Invitrogen, A21201) 1/500 for IF, Alexa 594-conju-
gated goat anti-rabbit antibody (Molecular probes, A11037) 1/500 for IF, and Alexa 647-conjugated goat anti-mouse antibody
(Thermo Fisher Scientific, A21235) 1/500 for IF, ATTO 647N-conjugated goat anti-rabbit antibody (Sigma-Aldrich , 40839) 1/2000
for IF and HRP-conjugated mouse anti-rabbit antibody (Santacruz Biotechnology, sc-2357) 1/3000 for WB.Structure 28, 674–689.e1–e11, June 2, 2020 e6
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For Chlamydomonas RNA isolation, 5x108 cells were resuspended in 10 ml nitrogen-free medium (M-N/5) for 4 hours at 25C. The
cells were collected at 500 g for 5 minutes at room temperature and the pellet was resuspended in 1 ml of Buffer RLT (reagent from
Qiagen RNeasy Mini Kit) with 10 ml of 2-mercaptoethanol. Cells were homogenized by passing through a 20-gauge needle 20 times
and centrifuged at 11000 g for 5 minutes at room temperature. The supernatant was collected and RNA extraction was performed
with the RNeasy Mini Kit (Qiagen) according to manufacturer’s recommendation. Five micrograms of total RNA from each strain was
treated with 5 U of RNase-free DNase I (Thermo Fisher Scientific) in 50 ml reaction at 37C for 30minutes. The reactionwas terminated
by addition of 5 mL 50 mM EDTA and heat inactivation at 65C for 10 min. One microgram of DNase-treated RNA from each strain
were added to SuperScript IV VILO Master Mix (Thermo Fisher Scientific). The reverse transcription reactions were performed ac-
cording to manufacturer’s recommendation with the reverse transcription temperature set to 60C.
Protein Purification
Purification of hCCDC611-143 was carried out as follows. BL21(DE3) cells (New England Biolabs) that carried the pGAT3-hCCDC611-
143 plasmid were grown in LB media at 37 C till OD600 reached between 0.6-1.0, and the gene expression was induced by 0.5 mM
IPTG after cooling the cell cultures to 16 C. The cell cultures were grown at the temperature overnight. Collected cells were sus-
pended in 8ml of a lysis buffer (50mM Tris-HCl pH 8.0, 300mMNaCl, 1 mMEDTA, 5 mMDTT, 1x cOmplete Protease Inhibitor Cock-
tail EDTA-free (Roche)) per gram of cells. The lysis was carried out by sonication. Cell debris were removed by centrifuging at 32,000 g
for 45min at 4 C. The supernatant after the centrifugation was collected and loaded onto a GSTrap FF 16/10 column (GEHealthcare)
equilibrated with the lysis buffer without the protease inhibitor. After washing the column with the lysis buffer, bound molecules were
eluted with the same equilibrated buffer but 25 mM reduced L-glutathione. The elution was dialyzed against 5L of 30 mMTris-HCl pH
8.0 150 mM NaCl, 0.5 mM EDTA, 5 mM 2-mercaptoethanol at 4C overnight after tev protease was added. The cleaving of the His-
GST tag leaves the extra amino-acid sequenceGly-Ser at theN-terminus of hCCDC611-143. The dialyzed sample was further dialyzed
against 5L of 30 mM Tris-HCl pH 8.0 at 4C, 150 mM NaCl, 20 mM imidazole, 2 mM 2-mercaptoethanol at 4 C for four hours. The
sample was loaded onto a 5ml HisTrap HP column (GE Healthcare), and the flow through and the first 5ml wash were collected. The
collected sample was diluted three-fold with 20 mM Tris-HCl pH 8.0, 2 mM DTT and loaded onto a 5ml HiTrap Q HP column (GE
Healthcare) equilibratedwith 20mMTris-HCl pH 8.0, 50mMNaCl, 2mMDTT. The boundmolecules were elutedwith a linear gradient
to 600 mM NaCl. Peak fractions containing hCCDC611-143 were collected and concentrated to 2.5 ml to load onto a PD-10 column
(GE Heathcare) equilibrated with 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2%(v/v) glycerol, 2 mM DTT. Purified hCCDC611-143 was
concentrated and stored at -80 C after snap-freezing in liquid nitrogen (Figure S7D). hCCDC611-143; F128E/D129A mutant and SeMet
replaced hCCDC611-143 were purified in a similar way.
Purification of zCCDC611-168; F129E/D130A was carried out as follows. The supernatant of crude bacterial extracts containing
zCCDC611-168; F129E/D130A was prepared in a similar way to that of hCCDC611-143. However, we used C41 cells (Miroux and Walker,
1996) instead of BL21(DE3) and 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 2 mM 2-mercaptoethanol, 1 mM AEBSF.
5ml of Ni-NTA resin (Expedion) were added to the extracts and incubated at 4 C for 120min. The resin was washed with 50mM Tris-
HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 2 mM 2-mercaptoethanol and the same buffer but 30 mM imidazole. Bound molecules
were eluted with the same buffer but 300 mM imidazole. The GST-PreScission protease and EDTA at the final concentration of
0.5 mM were added to the elution, which was dialyzed against 5L of 30 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 2 mM
2-mercaptoethanol at 4 C overnight. The cleaving the His tag leaves the extra amino-acid sequence Gly-Pro-His at the N-terminus
of zCCDC611-168; F129E/D130A. 0.5ml of glutathione sepharose 4Bwere added to the dialyzed sample and incubated at 4 C for 60min.
The supernatant was collected, diluted three-fold with 20mMTris-HCl pH 8.0, 2mMDTT and loaded onto a 5ml HiTrapQHP column
equilibrated with 20 mM Tris-HCl pH 8.0, 50 mM NaCl, 2 mM DTT. Bound molecules were eluted with a linear gradient of 400 mM
NaCl. Peak fractions containing zCCDC611-168; F129E/D130A were collected. The buffer of the sample was exchanged to 20 mM Tris-
HCl pH8.0, 100 mM NaCl, 2 mM DTT by a PD-10 column and the protein stored at -80 C after concentration (Figure S7D).
Construct zCCDC611-170 fused to the C-terminus of a lipoyl-domain tag (Lipo-zCCDC611-170) (for SEC-MALS analysis) and its
F129E/D130A mutant (for SEC-MALS analysis) were expressed in E. coli C41 in 2xTY and purified by Ni-NTA (Qiagen) beads using
standardmethods. Subsequently, eluates were subjected to a size exclusion chromatography step in 10mMTris-HCl, pH 8.0, 50mM
NaCl, 2 mM DTT and the purifications finished by ion-exchange chromatography on a HiTrap Q-FF (GE Healthcare) column using a
linear salt gradient from 10 mM Tris-HCl, pH 8.0, 2 mM DTT to 10 mM Tris-HCl, pH 8.0, 2 mMDTT, 1 M NaCl. Proteins were concen-
trated and snap frozen in liquid nitrogen and stored at -80 C. To purify zCCDC611-170 without the lipoyl-domain tag, Lipo-zCCDC611-
170 was incubated with the tev protease after the Ni-affinity purification step. Cleaving the tag leaves the extra amino-acid sequence
Gly-Gly-Ser at the N-terminus of zCCDC611-170. The zCCDC611-170 solution was loaded onto a HisTrap FF column to remove the tag
and tev protease and then loaded onto a HiTrap Q HP column after being diluted to 175 mM NaCl concentration by 20 mM Tris-HCl
pH 8.0. The flow through fractions containing zCCDC611-170 were collected and loaded onto a PD-10 buffer exchange column equil-
ibrated with 10 mM Tris-HCl pH8.0, 300 mM NaCl, 2 mM DTT and concentrated before being snap-frozen in liquid nitrogen. Lipo-
zCCDC611-170; F129E/D130A used for Figure 2D was purified in a similar way.
Purification of zCCDC61146-280 was carried out as follows. A Ni-NTA affinity purification of zCCDC61146-280 was carried out in a
similar way to that of zCCDC611-168; F129E/D130A but using 500 mM NaCl in the purification buffers. GST-PreScission protease and
EDTA (at a final concentration of 0.5 mM) were added to the elution. Cleaving the tag leaves the extra amino acid sequence Gly-
Pro-His-Asn at the N-terminus of the protein. 1 ml of glutathione sepharose 4B were added to the sample and incubated at 4 Ce7 Structure 28, 674–689.e1–e11, June 2, 2020
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on to a 5 ml HiTrap Q HP equilibrated with 30 mM Tris-HCl pH8,0, 300 mM NaCl, 5 mM DTT. The flow through was collected and
concentrated to 3 ml before loading onto a Superdex 75 16/600 column (GE Healthcare) equilibrated with 20 m HEPES pH 7.5,
500 mM NaCl, 2 mM DTT. Fractions containing zCCDC61146-280 were collected and diluted two-fold with 20 mM HEPES pH 7.5
before loading onto a 5 ml HiTrap Heparin HP column equilibrated with 20 m HEPES pH 7.5, 200 mM NaCl, 2 mM DTT. Bound mol-
ecules were eluted with a linear gradient of 20 m HEPES pH7.5, 1 M NaCl, 2 mM DTT. Fractions containing zCCDC61146-280 were
collected, and the buffer of the protein was exchanged to 20 mM HEPES pH 7.5, 200 mM NaCl, 2 mM DTT using a PD-10 column.
The sample was concentrated to a desired concentration and snap frozen in liquid nitrogen before storing at -80 C (Figure S7D).
zCCDC61146-280; 5Emutant was purified in a similar way to zCCDC61146-280, but a HiTrapQHP columnwas used instead of the HiTrap
Heparin HP column. The protein has the extra amino-acid sequence Gly-Pro-His-Asp at its N-terminus.
Purification of hCCDC61288-512 was carried out in a similar manner to zCCDC611-170. hCCDC61288-512 fused to the C-terminus of a
lipoyl-domain tag was expressed in E. coli C41. All following steps were carried out at room temperature because hCCDC61288-512
tends to precipitate at 4 C. After the Ni-NTA step, the eluted proteins were loaded onto a 5ml HiTrap Heparin HP column (GE Health-
care) equilibrated with 20 mM HEPES pH 7.5, 300 mM NaCl, 2 mM DTT. Bound proteins were eluted with a linear gradient of 20 mM
HEPES pH 7.5, 1 M NaCl, 2 mM DTT. Fractions containing hCCDC61288-512 were collected and the lipoyl tag was cleaved by adding
tev protease, which leaves the extra amino-acid sequence Gly-Gly-Ser at the N-terminus of hCCDC61288-512. The cleaved sample
was passed onto a 5 ml HisTrap HP column. The flow through was collected and dialyzed against 3L of 20 mM HEPES pH 7.5,
500mMNaCl, 2 mMDTT. The dialysed sample was concentrated and stored at -80 C after snap frozen in liquid nitrogen (Figure 3C).
To stabilise hCCDC61144-287 and hCCDC61144-287; 5E, both constructs were fused to the C-terminus of residue 1-137 of PAXX (Ochi
et al., 2015) and cloned into pSKB2LNB vector. The proteins were expressed and purified using Ni-NTA as described above. Eluted
proteins were cleaved with the GST-PreScission protease and dialyzed in 2L of 30 mM Tris-HCl pH 8.0, 2 mM 2-mercaptoethanol
overnight suppliedwith 500mMNaCl (hCCDC61144-287) and 200mMNaCl (hCCDC61144-287; 5E) at 4C. The cleavage leaves the extra
amino-acid sequence Gly-Pro-His at the N-terminus of these constructs. As for hCCDC61144-287, the dialyzed sample was diluted
two-fold with 20 mM Tris-HCl pH8.0, 2 mM DTT and loaded on to tandemly connected 5 ml GSTrap and HiTrap Q HP equilibrated
with 30 mM Tris-HCl pH 8.0, 300 mM NaCl, 2 mM DTT. The flow through was loaded onto a 5 ml HiTrap Heparin HP column equil-
ibrated with 20 mM HEPES pH 7.5, 200 mM NaCl, 2 mM DTT. Bound proteins were eluted with a linear gradient of 20 mM HEPES
pH7.5, 1 M NaCl, 2 mMDTT. The fractions containing hCCDC61144-287 were collected and passed onto a PD-10 column equilibrated
with 20 mMHEPES pH 7.5, 500 mMNaCl, 2 mMDTT. The purified protein was concentrated and stored at -80C after snap freezing
in liquid nitrogen (Figure 3C). As for hCCDC61144-287; 5E, the dialyzed sample was diluted two-fold with 50mMHEPESpH7.5, 5mM2-
mercaptoethanol and loaded onto a 5 ml GSTrap column. The flow through was loaded onto a 5 ml HiTrap Q HP column equilibrated
with 20mMHEPES pH 7.5, 100mMNaCl, 2 mMDTT. Bound proteins were eluted with a linear gradient of 20mMHEPES pH 7.5, 1M
NaCl, 2 mM DTT. The fractions containing hCCDC61144-287; 5E were collected and diluted with 20 mM HEPES pH 7.5, 200 mMNaCl,
2 mM 2-mercaptoethanol. The diluted sample supplied with 20 mM imidazole was loaded onto a 5 ml HisTrap HP column, and the
flow through was collected. The protein was concentrated and diluted with 20 mM HEPES pH7.5, 200 mM NaCl, 2 mM DTT. The
procedure was repeated three times. Finally, the concentrated sample was stored at -80 C after snap freezing in liquid nitrogen
(Figure S4D).
For purification of 15N-labelled human SAS6, DNA encoding human SAS61-143 was cloned into pSKB2LNB vector. This construct
was expressed in E. coli Rosetta in minimal medium containing 15NH4Cl and purified by standard methods using Ni-NTA (Qiagen)
chromatography. The eluate was dialyzed (in the presence of GST-PreScission protease) against 10 mM Tris-HCl, pH 8.0, 2 mM
DTT and further purified by ion-exchange chromatography on a HiTrap Q-FF (GE Healthcare) column using a linear salt gradient
from 0 mM to 1 M NaCl in 10 mM Tris-HCl, pH 8.0, 2 mM DTT followed by size exclusion chromatography in 20 mM Tris-HCl, pH
8.0, 150 mM NaCl, 2 mM DTT (Figure S7D).
GFP nanobody was purified based on a published protocol (Kubala et al., 2010). BL21(DE3) cells that carried the pHAT5-GFP-
nanobody plasmid were grown in 6L of LB media at 37 C till OD600 reached between 0.6-1.0, and the gene expression was induced
by 1 mM IPTG after cooling the cell cultures to 16 C. The cell cultures were grown at the temperature overnight. Collected cells were
suspended in 5 ml of a lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 5%(v/v) glycerol, 0.1%(v/v) NP-40, 10 mM imidazole, 1x
cOmplete Protease Inhibitor Cocktail EDTA-free) per gram of cells. The lysis was carried out by sonication. Cell debris were removed
by centrifuging at 27,000 g for 30 min at 4 C. The supernatant after the centrifugation was collected and loaded onto 2x 5ml HisTrap
HP columns (GE Healthcare) equilibrated with the lysis buffer without the protease inhibitor. The column was washed with 50 mM
HEPES pH7.5, 1 M NaCl, 0.2%(v/v) NP-40, 50 mM imidazole and 50 mMHEPES pH7.5, 500 mMNaCl, 50 mM imidazole. The bound
molecules were eluted with 50 mM HEPES pH7.5, 500 mM NaCl, 300 mM imidazole. The elution was dialyzed against 5L of 0.2 M
NaHCO3 pH8.3, 500 mM NaCl at 4
C overnight. Dialyzed GFP nanobody was concentrated and stored at -80 C after snap-freezing
in liquid nitrogen.
Protein Crystallization
SeMet hCCDC611-143 was crystallized at 20C in a hanging drop containing 10mg/ml of the protein and 8% (w/v) PEG6,000, 100mM
Tris-HCl pH 7.3 in a 1:1 ratio. zCCDC611-168; F129E/D130A was crystallized at 20C in a sitting drop containing 10 mg/ml of the protein
and 8% (w/v) PEG 6,000, 100mMBicine pH 9.0, 3% Trimethylamine N-Oxide in a 1:1 ratio. zCCDC611-170 was crystallized at 20C in
a sitting drop containing 4.62mg/ml of the protein and 100mMCitric acid pH 5.0, 1M LiCl in a 1:1 ratio. Single crystals of the proteinsStructure 28, 674–689.e1–e11, June 2, 2020 e8
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X-ray Crystallography
Diffraction images of the crystals were collected at I02 in Diamond Light Source (DLS) for SeMet hCCDC611-143, at MRC LMB using
an in-house X-ray diffraction machine (RIGAKU FR-E+ SuperBright) for zCCDC611-168; F129E/D130A and at I03 in DLS for zCCDC611-
170. The collected data were indexed and integrated using XDS (Kabsch, 2010) for the SeMet hCCDC611-143 data, iMOSFLM (Battye
et al., 2011) for zCCDC611-168;F129E/D130A and zCCDC611-170 data, and scaled using Aimless (Evans, 2011), which were run from
CCP4 program suite (Winn et al., 2011). The phenix.autosol module of PHENIX suite (Adams et al., 2010) was used to calculate
phases for structure factors of the SeMet hCCDC611-143 data by the SAD method. Phases for structure factors of the zCCDC611-
168; F129E/D130A or zCCDC611-170 data were determined by the phenix.phaser module using the structure of SeMet hCCDC611-143
or zCCDC611-168; F129E/D130A as a probe for molecular replacement respectively. The initial structures were build using the phenix.-
autobuild module. The models were refined manually using Coot (Emsley et al., 2010) and computationally using the phenix.refine
module until no further improvements of the map were observed. TLS groups were selected as each chain for hCCDC611-143 and
as each chain divided into two groups (from N-terminus to residue 144 and from 145 to the C-terminus) for zCCDC611-168; F129E/
D130A and zCCDC611-170. Non-crystallographic symmetry restraints were not applied for the refinement of these structures. For
the refinement of zCCDC611-170, E129 and A130 of zCCDC611-168; F129E/D130A were replaced with F129 and D130, and the model
was refined as described above. The final structural models were validated using MolProbity (Williams et al., 2018) run from PHENIX
suite. All protein-structure graphics were produced using PyMOL (Schrödinger, 2015).
Analytical Ultracentrifugation
hCCDC611-143 and hCCDC611-143; F128E/D129A at approximately 480 mM (7.9 mg/ml) in 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM
DTT were subjected to velocity sedimentation at 50,000 rpm at 4C in an An50Ti rotor using an Optima XL-I analytical ultracentrifuge
(Beckmann). The data were analysed in SEDFIT 15.0 (Schuck, 2003) using a c(s) distribution model. The partial-specific volumes (v-
bar), solvent density and viscosity were calculated using Sednterp (Dr Thomas Laue, University of NewHampshire). To determine the
dissociation for dimerization, Kd, of hCCDC61
1-143 homodimer, 110 mL with total protein concentrations of 12, 4 and 1.3 mg/ml were
loaded in 12 mm 6-sector cells and centrifugated at 11,600, 19,700 and 34,000 rpm at 4C until equilibrium had been reached. Data
were processed and analyzsed using SEDPHAT 13b (Schuck, 2003). Data were plotted with the program GUSSI (Brautigam, 2015).
SEC-MALS
The mass and hydrodynamic radius of CCDC61 constructs in solution was determined using SEC-MALS as described previously
(van Breugel et al., 2011). SEC was in 10mM Tris-HCl pH 7.4, 150mM NaCl (1, 6.5 and 65 mg/ml of His6-lipoyl-zCCDC61
1-170 and
1, 6.8 and 73 mg/ml of its F129E/D130A mutant). SEC used a Superdex S200 10/300 column (GE Healthcare) running at 0.5 ml/
min. The concentrations quoted are at loading and these will be at least 10 times lower during chromatography due to dilution on
the column. Experiments were performed at room temperature. Since the coiled-coil regions present in His6-lipoyl-zCCDC61
1-170
and its mutant are very short (20 amino acids), coiled-coil dimerization is inefficient, explaining the presence of monomer species
in the SEC-MALS runs.
Circular Dichroism (CD)
Purified zCCDC61146-280 and its 5E mutant were dialyzed against 1L of 20 mM sodium phosphate pH7.5, 500 mMNaCl, 1 mM TCEP
at 4C overnight and adjusted to a concentration of 0.375 mg/ml. The CDmeasurement was done at 5C. Far-UV CD spectra at 5C
and thermal melts at 222 nm were measured using a Jasco J815 spectropolarimeter (JASCO (UK) Ltd) in 20 mM sodium phosphate
pH7.5, 500 mM NaCl, 1 mM TCEP. Following dialysis into this buffer, samples of zCCDC61146-280 and its 5E mutant were diluted to
0.375 mg/ml and measured in a 1 mm pathlength cuvette. Thermal melts were performed at a heating rate of 1C/min.
NMR
NMR data were collected at 20C on a Bruker Avance II+ 700 MHz spectrometer, equipped with a cryogenic triple-resonance TCI
probe. 2D 1H,15N BEST-Trosy data sets for 56 mM of 15N-labelled hSAS61-143 on its own and in the presence of 48 mM of
hCCDC611-143 were acquired in 20 mM Tris pH8.0, 150 mM NaCl and 2 mM DTT. Data were processed using Topspin 3.0 (Bruker)
and analyzed using SPARKY (T. D. Goddard and D. G. Kneller – University of California, San Francisco).
Microtubule Pelleting Assay
Taxol-stabilized microtubules were prepared as described on Anthony Hyman’s lab website (http://hymanlab.mpi-cbg.de/
hyman_lab/wp-content/uploads/2012/08/Tubulin-Protocols-Mitchison.pdf). All centrifugation steps were carried out in 7 x 20 mm
polycarbonate-centrifuge tubes using a TLA100 rotor and Optima TL ultracentrifuge (Beckman Culture). 20 mM Tubulin purified
from pig brains (a kind gift of Dr. Andrew Carter, MRC LMB, Cambridge, UK) were polymerized at 37C in BRB80 (80 mM PIPES
pH 6.8, 1 mM MgCl2, 1 mM EGTA) supplied with 1 mM GTP and 1 mM DTT by adding 1/10 volume of 2, 20 and 200 mM of Taxol
stepwise. Taxol-stabilized microtubule were pelleted by centrifugation at 70,000 rpm for 12 min at 25C. The microtubule pellets
were resuspended in the reaction buffer (20 mM Tris-HCl pH7.4, 200 mM NaCl, 1 mM DTT, 20 mM Taxol). In order to find an optimal
tubulin / subtilisin ratio for removing the tubulin C-termini, we first mixed 2mg/ml tubulins with a four-fold dilution series of subtilisin Ae9 Structure 28, 674–689.e1–e11, June 2, 2020
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nated by adding 10 mM PMSF and incubated at 37C for 5 min before being centrifuged to pellet microtubules. 20 mM of CCDC61
constructs in the reaction buffer were spun at 70,000 rpm for 12 min at 25C. 45 ml of the supernatant of each construct were mixed
with the equal volume of 20 mMof the stabilized microtubules in reaction buffer. The mixed samples were incubated at RT for 15 min.
85 ml of the mixed samples were centrifuged through a cushion of 50 ml of the reaction buffer supplied with 40%(v/v) glycerol at
70,000 rpm for 30 min at 25 C. The supernatants and pellets were analyzed using SDS-PAGE. Mixed samples before the ultracen-
trifugation step were also used for negative-stain EM visualization.
Knockout and Knockdown of hCCDC61
Knockout of CCDC61 in RPE-1 PuroKO cells (Balmus et al., 2019) was done using methods and reagents as described before
(Chiang et al., 2016). Briefly, two target sites in exon 1 of CCDC61 (5’-GGAAGACGTAGTCCACCTGCAGG-3’ and 5’-GGAG-
CATGCCGTGCGGGTGATGG-3’) of Cas9 were designed by CRISPR DESIGN (Hsu et al., 2013). The all-in-one plasmid encoding
these sites (AIO-GFP-hCCDC61) was transfected to RPE-1 cells by electroporation using the NEON transfection system (Thermo
Fisher). After 48 hours, GFP-positive cells were FACS sorted in three 96-well plates at the Cambridge Stem Cell Institute, University
of Cambridge. Cells were incubated at 37C in 5% CO2 about a month till they became confluent. Genomic DNAs of the cells were
extracted using QuickExtract DNA extraction solution (Cambio) and subjected to PCR using two primers (5’-
TTCCAGGGTTCCATGGGTCTAGGTTTCTCTCTCATCTCCTT
-3’ and 5’-CGAGGTCGACGAATTCGGCACACTCACAGCCAGCATCGAA
-3’). The PCR products were cloned into a pHAT4 (Per€anen et al., 1996) vector to be sequenced. Two clones that had inserts
causing premature stop codons in both alleles of the exon (Figure S5A) were selected for further studies. For counting of the centriole
number, parental and CCDC61 knockout cell lines were treated with 100 mM monastrol (Sigma-Aldrich) for 4 hours. For ciliation
assay, cells were serum starved in media containing 0.5% FBS for 24 and 48 hours. To determine proliferation kinetics, cells
were seeded in 12well plate at 5x103 cells/well and real-time quantitative live cell analysis was carried out for 96 hours using IncuCyte
ZOOM (Essen BioScience), imaging 9 positions per well every 3 hours.
Knockdown of CCDC61 was carried out by transfecting three different Silencer Select siRNAs (siRNA IDs: s59736 as siRNA 1,
s59737 as siRNA 2 and s59738 as siRNA 3) (Life Technologies) or (Ambion control siRNA) to RPE-1 cells. Briefly, RPE-1 cells
were transfected with Lipofectamine RNAiMAX reagent (Thermo Fischer Scientific). The siRNAs were used at a final concentration
of 60 nM and the siRNA treatments were carried out for 72 hours after transfection. To assess ciliation, 48 hours after siRNA trans-
fection RPE-1 cells were serum starved in media containing 0.5% FBS for 24 hours. Knockdown efficiencies were assessed by
reverse transcription PCR (RT-PCR) using a forward primer (5’-TGCAGCGATTTGGAGGATTT-3’) and a reverse primer (5’-
CGGAGTTGGCCAGAGATTTC-3’).
Fluorescent and Immunofluorescent Microscopy
GFP-hCCDC61 constructs were transfected to RPE-1 cells using Lipofectamine 3000 (Thermo Fisher Scientific) by mixing 500 ng
of each pEGFP-C1-hCCDC61 construct with 1 ml of P3000 reagent and 1 ml of Lipofectamine 3000 reagent in Opti-MEM (Thermo
Fisher Scientific) before adding the mixture to the cells grown on a coverslip in a well of a 24-well plate. After 24 hours of trans-
fection, cells were fixed with 4% (w/v) formaldehyde for fluorescent microscopy or cold methanol and stained with antibodies for
immunofluorescent microscopy as indicated in the main text. ProLong Diamond Antifade Mountant (Thermo Fisher Scientific) was
used as a mounting media. Confocal images of fixed cells were taken using a Confocal White Light Laser (WLL) Leica TCS SP8
Microscope with the HC Plan Apo 40x/1.30 63x/1.40 or 100 x/1.40 OIL (CS2) objective or a Zeiss LSM880 AxioObserver with Plan-
Apochromat 40x/1.40. Image acquisition was carried out with the Leica Application Suite X (LAS X) software (Leica Microsystems)
or Zen software (Zeiss). Wide-field images of fixed cells (Figure 4C) were taken using the Nikon Eclipse TE2000 Inverted Micro-
scope with the Plan Apo VC 60 x or 100 x/1.40 OIL objective. After acquisition, images were imported into Fiji (Schindelin et al.,
2012) to obtain maximum intensity projections of entire z-stacks. Fiji and Photoshop (Adobe, 2017) were used to perform level
adjustment. The immunofluorescent image shown in Figure 4A was generated by deconvoluting the original image using Huygens
Professional (Scientific Volume Imaging). For Chlamydomonas immunofluorescence, 107 Chlamydomonas cells were first resus-
pended in 0.5 ml M-N/5 medium for 4 hours to allow flagellar assembly. Cells were then treated with autolysin for 30 min at 25C to
remove cell walls, followed by resuspension in 1 ml MTSB (microtubule stabilization buffer, 30 mM HEPES, pH 7.4, 5 mM MgSO4,
15 mM KCl, 2 mM EGTA) at room temperature. Fifty microliters of cells were applied to a 0.1% poly-L-Lysine (Sigma-Aldrich)
coated well on a multi-well slide (Thermo Fisher Scientific) for 2 minutes in the dark. Excess cell suspension was removed by pi-
petting. Fifty microliters of lysis buffer (MTSB + 1% NP-40) was added to each well to lyse the cells for 2 minutes at room tem-
perature. MTSB was used to wash individual wells once and removed by pipetting. Samples were fixed with MTSB + 4% para-
formaldehyde for 30 minutes at room temperature. Excess liquid was removed by pipetting before slides were submerged in cold
methanol (20C) for 2 3 5 min and left to dry at room temperature. The remained nucleo-flagellar apparatuses attached to the
wells were rehydrated with the addition of PBS (phosphate-buffered saline) for 10 minutes at room temperature. After rehydration,
the samples were blocked with 100% blocking buffer (5% BSA and 1% fish gelatin in PBS) for 1 hour at room temperature, fol-
lowed by inoculation with primary antibodies (diluted with 20% blocking buffer) at 4C overnight. The samples were washed six
times with 20% blocking buffer, followed by 1 hour inoculation at room temperature with secondary antibodies diluted with 20%
blocking buffer. The samples were washed six times with 20% blocking buffer and mounted in Fluoromount-G (Southern Biotech).Structure 28, 674–689.e1–e11, June 2, 2020 e10
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software (PerkinElmer).
Live Cell Imaging
RPE-1 cells were grown on a chambered cover glass (Grace Bio-Labs) in D-MEM/F-12 without phenol red (Thermo Fisher Scientific)
supplied with 10% FBS, and 100 units of penicillin and 100 mg/ml of streptomycin and transfected with GFP-hCCDC61 using Lip-
ofectamine 3000 (Thermo Fisher Scientific). After 24 hours, the media were replaced with the same media with 0.1% (v/v) DMSO
or with 5 mg/ml nocodazole, and confocal fluorescent images of GFP positive RPE-1 cells were taken using a Zeiss LSM880 AxioOb-
server with Plan-Apochromat 40x/1.40, maintained at 37C, at time points 0, 60, 120, and 180 min.
GFP Pulldown Assays
HEK293T cells were grown nearly confluent in 10 cm dishes containing D-MEM glutaMAX (Thremo Fisher Scientific) supplied with
10% FBS. A GFP construct (pEGFP-C1, pEGFP-C1-hCCDC611-457; F128E/D129A or pEGFP-C1-hCCDC611-457; F128E/D129A/5E) and
HA construct (pcDNA3-3xHA-hCCDC611-457; F128E/D129A or pcDNA3-3xHA-hCCDC611-457; F128E/D129A/5E) were co-transfected into
the cells using PEI (Polysciences) as indicated in Figure S4E. The cells were collected after 24 hours of the transfection. GFP-affinity
resins were prepared by conjugating purified GFP nanobody to NHS-activated resins (GE Healthcare). The cells were lysed in 1 ml of
50 mM Tris pH 7.4, 200 mMNaCl, 0.2%(v/v) NP-40, 10%(v/v) glycerol, 1x cOmplete Protease Inhibitor Cocktail EDTA-free on ice for
30min. Debris was removed by centrifuging at 21,000 g, 4 C for 30min. 30 ml of the GFP affinity resins were added to the supernatant
and incubated on a rotating disk at 4C for 90 min. The resins were washed five times with the lysis buffer and mixed with 30 ml of 2x
SDS sample buffer. Eluted proteins were separated by SDS-PAGE and subject to western blot.
Xenopus Embryos
Xenopus Laevis embryos culture and injection were carried out as described (Hörmanseder et al., 2017). xCCDC61-RFP (0.1ng),
Centrin2-BFP (0.25ng) and Clamp-GFP (0.25ng) mRNAs were injected in one cell stage embryos. Following injection embryos
were cultured at 14C to the tailbud stage (stage 27/28 (Faber and Nieuwkoop, 1994)). Embryos were then fixed for 15min in MEMFA
(100mMMOPS PH6.8, 2mM EGTA, 1mMMgSO4, 4% formaldehyde), washed 3X in 0.1XMBS (MBS (Barth-Hepes Saline) 10X stock
: 88 mM NaCl, 1 mM KCl, 2,4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 10 mM HEPES pH 7.4-7.6), and
equilibrated overnight at 4C in 0.1XMBS 50% glycerol. The fixed whole embryos were mounted onto glass slides with ProLong Dia-
mond Antifade Mountant (Thermo Fisher Scientific) and sandwiched with coverslips using a few layers of electrical tape as spacers
(Werner and Mitchell, 2013) for confocal imaging.
FACS
The day before FACS experiments, 0.5x106 RPE-1 cells were seeded onto each well of a 6-well plate containing 2 ml of the RPE-1
growth media per well. On the next day, Hoechst 33342 (EMP Biotech) was added to the media at the final concentration of 2 mMand
incubated at 37C with 5% CO2 for 60 min before the cells were trypsinized and pelleted. The cells were re-suspended in 500 ml of
PBS and analysed by flow cytometry using an iCyt EC800 cell analyser (Sony Biotechnology). The resulting cell-cycle distribution of
cell singlets was determined using FCS EXPRESS 6 Flow software (De Novo Software).
Electron Microscopy
For negative staining, 3 ml of sample were applied onto a 400-mesh carbon-coated copper grid (EMS) that was glow discharged and
incubated for 1min at room temperature. After blotting onto filter paper, the grid waswashed twice with 5 ml of water and stained with
5 ml of 2%(w/v) uranium acetate for 1min. The grid was then blotted onto filter paper and air dried. Micrographswere collected using a
Tecnai T12 (FEI) operated at 120 kV and equipped with an Orius SC200 or Ultrascan 1000 XP CCD detector (Gatan). Widths of mi-
crotubules were measured using Fiji.
QUANTIFICATION AND STATISTICAL ANALYSIS
We calculated average and standard deviation values using AVERAGE and STDEV functions in Microsoft Excel for Figures 3A, 3E,
4C, S4B, S5B, and S5D, and in GraphPad Prism for Figure S5E. For Figure 5A, c2 analysis was performed using the website (https://
wwwsocscistatistics.com/tests/chisquare/). The number of cells with no cilia and the total number of cells were used in pairwise cal-
culations. Sample sizes n are provided in figure legends. For the statistical analysis of X-ray crystallography data, details are pro-
vided above.e11 Structure 28, 674–689.e1–e11, June 2, 2020
